JA

Profile

Research

Social

Other

Kumanogou Atsushi

熊ノ郷 淳

Graduate School of Medicine Division of Medicine, Professor

keyword Immunology

Education

  • - 1997, Osaka University
  • - 1997, Osaka University, Graduate School, Division of Medicine
  • - 1991, Osaka University, Faculty of Medicine, Medical School
  • - 1991, Osaka University, Faculty of Medicine

Research Areas

  • Life sciences, Allergies and connective tissue disease
  • Life sciences, Immunology

Professional Memberships

  • 日本骨免疫学会
  • 日本炎症・再生学会
  • 日本臨床免疫学会
  • American Society for Clinical Investigation
  • 日本リウマチ学会
  • 日本内科学会
  • 日本免疫学会

Papers

  • Olig2-Induced Semaphorin Expression Drives Corticospinal Axon Retraction After Spinal Cord Injury., Masaki Ueno,Yuka Nakamura,Hiroshi Nakagawa,Jesse K Niehaus,Mari Maezawa,Zirong Gu,Atsushi Kumanogoh,Hirohide Takebayashi,Qing Richard Lu,Masahiko Takada,Yutaka Yoshida, Cerebral cortex (New York, N.Y. : 1991), Vol. 30, No. 11, p. 5702-5716, 2020/10/01
  • Tet DNA demethylase is required for plasma cell differentiation by controlling expression levels of IRF4., Kentaro Fujii,Shinya Tanaka,Takanori Hasegawa,Masashi Narazaki,Atsushi Kumanogoh,Haruhiko Koseki,Tomohiro Kurosaki,Wataru Ise, International immunology, Vol. 32, No. 10, p. 683-690, 2020/09/30
  • Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CT., Jun Nakata,Kayako Isohashi,Soyoko Morimoto,Ryota Itou,Takashi Kamiya,Ai Matsuura,Hiroko Nakajima,Fumihiro Fujiki,Sumiyuki Nishida,Yoshiko Hasii,Kana Hasegawa,Shinichi Nakatsuka,Naoki Hosen,Akihiro Tsuboi,Yoshihiro Oka,Atsushi Kumanogoh,Masaru Shibano,Satoru Munakata,Yusuke Oji,Jun Hatazawa,Haruo Sugiyama, Medicine, Vol. 99, No. 39, 2020/09/25
  • Metabolomic analysis of fibrotic mice combined with public RNA-Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis., Yosui Nojima,Yoshito Takeda,Yohei Maeda,Takeshi Bamba,Eiichiro Fukusaki,Mari N Itoh,Kenji Mizuguchi,Atsushi Kumanogoh, FEBS open bio, 2020/09/22
  • Increased levels of plasma nucleotides in patients with rheumatoid arthritis., Toshihiro Kishikawa,Yuichi Maeda,Takuro Nii,Noriko Arase,Jun Hirata,Ken Suzuki,Kenichi Yamamoto,Tatsuo Masuda,Kotaro Ogawa,Shigeyoshi Tsuji,Masato Matsushita,Hidetoshi Matsuoka,Maiko Yoshimura,Shinichiro Tsunoda,Shiro Ohshima,Masashi Narazaki,Atsushi Ogata,Yukihiko Saeki,Hidenori Inohara,Atsushi Kumanogoh,Kiyoshi Takeda,Yukinori Okada, International immunology, 2020/08/31
  • Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation., Mikito Shimizu,Tatsusada Okuno,Makoto Kinoshita,Hisae Sumi,Harutoshi Fujimura,Kazuya Yamashita,Tomoyuki Sugimoto,Shuhei Sakakibara,Kaori Sakakibara,Toru Koda,Satoru Tada,Teruyuki Ishikura,Hisashi Murata,Shohei Beppu,Naoyuki Shiraishi,Yasuko Sugiyama,Yuji Nakatsuji,Atsushi Kumanogoh,Hideki Mochizuki, Scientific reports, Springer Science and Business Media LLC, Vol. 10, No. 1, p. 13274-13274, 2020/08/06
  • Revisiting Cell Death Responses in Fibrotic Lung Disease: Crosstalk between Structured and Non-Structured Cells., Kiyoharu Fukushima,Takashi Satoh,Hiroshi Kida,Atsushi Kumanogoh, Diagnostics (Basel, Switzerland), Vol. 10, No. 7, 2020/07/21
  • Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis, Hiroyoshi Mori,Tomohiko Ishibashi,Tadakatsu Inagaki,Makoto Okazawa,Takeshi Masaki,Ryotaro Asano,Yusuke Manabe,Keiko Ohta-Ogo,Masashi Narazaki,Hatsue Ishibashi-Ueda,Atsushi Kumanogoh,Yoshikazu Nakaoka, Circulation Journal, Japanese Circulation Society, Vol. 84, No. 7, p. 1163-1172, 2020/06/25
  • Host Immune Response and Novel Diagnostic Approach to NTM Infections., Yuko Abe,Kiyoharu Fukushima,Yuki Hosono,Yuki Matsumoto,Daisuke Motooka,Naoko Ose,Shota Nakamura,Seigo Kitada,Hiroshi Kida,Atsushi Kumanogoh, International journal of molecular sciences, Vol. 21, No. 12, 2020/06/18
  • Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study., Kosuke Ebina,Toru Hirano,Yuichi Maeda,Wataru Yamamoto,Motomu Hashimoto,Koichi Murata,Tohru Takeuchi,Hideyuki Shiba,Yonsu Son,Hideki Amuro,Akira Onishi,Kengo Akashi,Ryota Hara,Masaki Katayama,Keiichi Yamamoto,Atsushi Kumanogoh,Makoto Hirao, Arthritis research & therapy, Vol. 22, No. 1, p. 142-142, 2020/06/15
  • Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody: associated vasculitis-a meta-analysis., Kentaro Kuzuya,Takayoshi Morita,Atsushi Kumanogoh, RMD open, Vol. 6, No. 1, 2020/04
  • Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis., Kiyoharu Fukushima,Takashi Satoh,Fuminori Sugihara,Yuki Sato,Toru Okamoto,Yuichi Mitsui,Sachiyo Yoshio,Songling Li,Satoshi Nojima,Daisuke Motooka,Shota Nakamura,Hiroshi Kida,Daron M Standley,Eiichi Morii,Tatsuya Kanto,Motoko Yanagita,Yoshiharu Matsuura,Takashi Nagasawa,Atsushi Kumanogoh,Shizuo Akira, Immunity, Vol. 52, No. 3, p. 542-556, 2020/03/17
  • Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase., Toru Koda,Akiko Namba,Makoto Kinoshita,Yuji Nakatsuji,Tomoyuki Sugimoto,Kaori Sakakibara,Satoru Tada,Mikito Shimizu,Kazuya Yamashita,Kazushiro Takata,Teruyuki Ishikura,Syo Murata,Shohei Beppu,Atsushi Kumanogoh,Hideki Mochizuki,Tatsusada Okuno, Journal of neuroinflammation, Vol. 17, No. 1, p. 82-82, 2020/03/13
  • Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study., Kosuke Ebina,Toru Hirano,Yuichi Maeda,Wataru Yamamoto,Motomu Hashimoto,Koichi Murata,Tohru Takeuchi,Koji Nagai,Yonsu Son,Hideki Amuro,Akira Onishi,Sadao Jinno,Ryota Hara,Masaki Katayama,Keiichi Yamamoto,Atsushi Kumanogoh,Makoto Hirao, Clinical rheumatology, 2020/03/11
  • Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors., Yoko Yamamoto,Kota Iwahori,Soichiro Funaki,Mitsunobu Matsumoto,Michinari Hirata,Tetsuya Yoshida,Ryu Kanzaki,Takashi Kanou,Naoko Ose,Masato Minami,Eiichi Sato,Atsushi Kumanogoh,Yasushi Shintani,Meinoshin Okumura,Hisashi Wada, Scientific reports, Vol. 10, No. 1, p. 4064-4064, 2020/03/04
  • Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells., Shigemi Sasawatari,Yuki Okamoto,Atsushi Kumanogoh,Toshihiko Toyofuku, Journal of immunology (Baltimore, Md. : 1950), Vol. 204, No. 5, p. 1373-1385, 2020/03/01
  • Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis., Takeshi Tsuda,Masayuki Nishide,Yohei Maeda,Yoshitomo Hayama,Shohei Koyama,Satoshi Nojima,Hyota Takamatsu,Daisuke Okuzaki,Takayoshi Morita,Takeshi Nakatani,Yasuhiro Kato,Yoshimitsu Nakanishi,Yu Futami,Yasuhiko Suga,Yujiro Naito,Hachiro Konaka,Shingo Satoh,Maiko Naito,Mayuko Izumi,Sho Obata,Ayaka Nakatani,Takashi Shikina,Kazuya Takeda,Masaki Hayama,Hidenori Inohara,Atsushi Kumanogoh, The Journal of allergy and clinical immunology, Vol. 145, No. 3, p. 843-854, 2020/03
  • Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood., Yujiro Naito,Akio Osa,Kentaro Masuhiro,Takashi Hirai,Shohei Koyama,Atsushi Kumanogoh, Journal of visualized experiments : JoVE, No. 156, 2020/02/05
  • OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE., Yumiko Mizuno,Masayuki Nishide,Taku Wakabayashi,Kohji Nishida,Atsushi Kumanogoh, Annals of the rheumatic diseases, Vol. 79, No. 2, 2020/02
  • Severe myocarditis with slight lymphocytic infiltration after nivolumab treatment., Ryuya Edahiro,Takayuki Shiroyama,Sachiko Hijiki,Satoshi Nojima,Yuya Shirai,Shohei Koyama,Atsushi Kumanogoh, Lung cancer (Amsterdam, Netherlands), Vol. 140, p. 116-117, 2020/02
  • Real-Time Monitoring and Detection of Single-Cell Level Cytokine Secretion Using LSPR Technology., Chen Zhu,Xi Luo,Wilfred Villariza Espulgar,Shohei Koyama,Atsushi Kumanogoh,Masato Saito,Hyota Takamatsu,Eiichi Tamiya, Micromachines, Vol. 11, No. 1, 2020/01/19
  • LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway., Toshihiko Toyofuku,Yuki Okamoto,Takako Ishikawa,Shigemi Sasawatari,Atsushi Kumanogoh, The EMBO journal, Vol. 39, No. 2, 2020/01/15
  • A case of SAPHO syndrome with the lesions limited to the skull., Eri Oguro,Yasuhiro Kato,Hyota Takamatsu,Masashi Narazaki,Atsushi Kumanogoh, Rheumatology advances in practice, Vol. 4, No. 2, 2020
  • The therapeutic efficacy of denosumab for the loss of bone mineral density in glucocorticoid-induced osteoporosis: a meta-analysis., Yuta Yamaguchi,Takayoshi Morita,Atsushi Kumanogoh, Rheumatology advances in practice, Vol. 4, No. 1, 2020
  • A Microfluidic Platform for Single Cell Fluorometric Granzyme B Profiling., Jonathan C Briones,Wilfred V Espulgar,Shohei Koyama,Hiroyuki Yoshikawa,JeongHoon Park,Yujiro Naito,Atsushi Kumanogoh,Eiichi Tamiya,Hyota Takamatsu,Masato Saito, Theranostics, Vol. 10, No. 1, p. 123-132, 2020
  • Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer., Miya Haruna,Michinari Hirata,Kota Iwahori,Takayuki Kanazawa,Yoko Yamamoto,Kumiko Goto,Atsunari Kawashima,Akiko Morimoto-Okazawa,Soichiro Funaki,Yasushi Shintani,Atsushi Kumanogoh,Hisashi Wada, Biological & pharmaceutical bulletin, Vol. 43, No. 3, p. 399-403, 2020
  • Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population., Toshihiro Kishikawa,Yuichi Maeda,Takuro Nii,Daisuke Motooka,Yuki Matsumoto,Masato Matsushita,Hidetoshi Matsuoka,Maiko Yoshimura,Shoji Kawada,Satoru Teshigawara,Eri Oguro,Yasutaka Okita,Keisuke Kawamoto,Shinji Higa,Toru Hirano,Masashi Narazaki,Atsushi Ogata,Yukihiko Saeki,Shota Nakamura,Hidenori Inohara,Atsushi Kumanogoh,Kiyoshi Takeda,Yukinori Okada, Annals of the rheumatic diseases, Vol. 79, No. 1, p. 103-111, 2020/01
  • Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice., Lisa Munakata,Yoshihiko Tanimoto,Akio Osa,Jie Meng,Yasunari Haseda,Yujiro Naito,Hirotomo Machiyama,Atsushi Kumanogoh,Daiki Omata,Kazuo Maruyama,Yasuo Yoshioka,Yoshiaki Okada,Shohei Koyama,Ryo Suzuki,Taiki Aoshi, Journal of controlled release : official journal of the Controlled Release Society, Vol. 313, p. 106-119, 2019/11/10
  • Monitoring antibody binding to T cells in a pembrolizumab-treated patient with lung adenocarcinoma on hemodialysis., Akio Osa,Takeshi Uenami,Yujiro Naito,Haruhiko Hirata,Shohei Koyama,Takayuki Takimoto,Takayuki Shiroyama,Shinji Futami,Saeko Nakatsubo,Nobuhiko Sawa,Yukihiro Yano,Izumi Nagatomo,Yoshito Takeda,Masahide Mori,Hiroshi Kida,Atsushi Kumanogoh, Thoracic cancer, Vol. 10, No. 11, p. 2183-2187, 2019/11
  • The therapeutic efficacy of intravenous immunoglobulin in anti-neutrophilic cytoplasmic antibody-associated vasculitis: a meta-analysis., Takashi Shimizu,Takayoshi Morita,Atsushi Kumanogoh, Rheumatology (Oxford, England), 2019/08/04
  • Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments., Sumiyuki Nishida,Akihiro Tsuboi,Atsushi Tanemura,Toshinori Ito,Hiroko Nakajima,Toshiaki Shirakata,Soyoko Morimoto,Fumihiro Fujiki,Naoki Hosen,Yusuke Oji,Atsushi Kumanogoh,Ichiro Kawase,Yoshihiro Oka,Ichiro Azuma,Satoshi Morita,Haruo Sugiyama, Medicine, Vol. 98, No. 33, 2019/08
  • A lung abscess caused by secondary syphilis - the utility of polymerase chain reaction techniques in transbronchial biopsy: a case report., Shinji Futami,Takayuki Takimoto,Futoshi Nakagami,Shingo Satoh,Masanari Hamaguchi,Muneyoshi Kuroyama,Kotaro Miyake,Shohei Koyama,Kota Iwahori,Haruhiko Hirata,Izumi Nagatomo,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, BMC infectious diseases, Vol. 19, No. 1, p. 598-598, 2019/07/09
  • The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors., Akiko Nakai,Jun Fujimoto,Haruhiko Miyata,Ralf Stumm,Masashi Narazaki,Stefan Schulz,Yoshihiro Baba,Atsushi Kumanogoh,Kazuhiro Suzuki, The Journal of experimental medicine, Vol. 216, No. 7, p. 1630-1647, 2019/07/01
  • Response to: 'Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?' by Liu et al., Yasuhiro Kato,JeongHoon Park,Hyota Takamatsu,Atsushi Kumanogoh, Annals of the rheumatic diseases, 2019/05/16
  • Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study., Kosuke Ebina,Motomu Hashimoto,Wataru Yamamoto,Toru Hirano,Ryota Hara,Masaki Katayama,Akira Onishi,Koji Nagai,Yonsu Son,Hideki Amuro,Keiichi Yamamoto,Yuichi Maeda,Koichi Murata,Sadao Jinno,Tohru Takeuchi,Makoto Hirao,Atsushi Kumanogoh,Hideki Yoshikawa, Arthritis research & therapy, Vol. 21, No. 1, p. 114-114, 2019/05/06
  • Unique Case of Pseudoprogression Manifesting as Lung Cavitation After Pembrolizumab Treatment., Kentaro Masuhiro,Takayuki Shiroyama,Izumi Nagatomo,Atsushi Kumanogoh, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Vol. 14, No. 5, 2019/05
  • Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis., Takayoshi Morita,Yoshihito Shima,Kosuke Fujimoto,Hideki Tsuboi,Yukihiko Saeki,Masashi Narazaki,Atsushi Ogata,Atsushi Kumanogoh, International immunology, Vol. 31, No. 5, p. 277-285, 2019/04/26
  • Transport of cellular misfolded proteins to the cell surface by HLA-B27 free heavy chain., Hideki Yorifuji,Noriko Arase,Masako Kohyama,Toru Hirano,Tadahiro Suenaga,Atsushi Kumanogoh,Hisashi Arase, Biochemical and biophysical research communications, Vol. 511, No. 4, p. 862-868, 2019/04/16
  • Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study., Kosuke Ebina,Motomu Hashimoto,Wataru Yamamoto,Toru Hirano,Ryota Hara,Masaki Katayama,Akira Onishi,Koji Nagai,Yonsu Son,Hideki Amuro,Keiichi Yamamoto,Yuichi Maeda,Koichi Murata,Sadao Jinno,Tohru Takeuchi,Makoto Hirao,Atsushi Kumanogoh,Hideki Yoshikawa, Arthritis research & therapy, Vol. 21, No. 1, p. 91-91, 2019/04/11
  • SEMA4A promotes eosinophil survival and contributes to eosinophil-mediated allergic diseases., Yohei Maeda,Takeshi Tsuda,Yoshito Takeda,Shohei Koyama,Yoshitomo Hayama,Satoshi Nojima,Tetsuya Kimura,Daisuke Ito,Hyota Takamatsu,Sujin Kang,Masayuki Nishide,Keiko Morimoto,Takashi Hosokawa,Yuhei Kinehara,Yasuhiro Kato,Takeshi Nakatani,Kazuya Takeda,Masaki Hayama,Sho Obata,Hitoshi Akazawa,Takashi Shikina,Hidenori Inohara,Atsushi Kumanogoh, Allergology international : official journal of the Japanese Society of Allergology, Vol. 68, No. 2, p. 274-276, 2019/04
  • 血清エクソソームの最新プロテオミクスによる新規COPDバイオマーカーの同定, 木庭 太郎,武田 吉人,玄山 宗到,木田 博,鳴海 良平,朝長 毅,伊藤 眞里,水口 賢司,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 8, No. 増刊, p. 139-139, 2019/03
  • Long-term outcomes of advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy followed by surgery: a 20-year experience., Ryu Kanzaki,Takashi Kanou,Naoko Ose,Soichiro Funaki,Yasushi Shintani,Masato Minami,Hiroshi Kida,Kazuhiko Ogawa,Atsushi Kumanogoh,Meinoshin Okumura, Interactive cardiovascular and thoracic surgery, Vol. 28, No. 3, p. 360-367, 2019/03/01
  • Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment., Kota Iwahori,Yasushi Shintani,Soichiro Funaki,Yoko Yamamoto,Mitsunobu Matsumoto,Tetsuya Yoshida,Akiko Morimoto-Okazawa,Atsunari Kawashima,Eiichi Sato,Stephen Gottschalk,Meinoshin Okumura,Atsushi Kumanogoh,Hisashi Wada, Scientific reports, Vol. 9, No. 1, p. 2636-2636, 2019/02/22
  • Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study., Takayuki Shiroyama,Izumi Nagatomo,Shohei Koyama,Haruhiko Hirata,Sumiyuki Nishida,Kotaro Miyake,Kiyoharu Fukushima,Yuya Shirai,Yuichi Mitsui,So Takata,Kentaro Masuhiro,Moto Yaga,Kota Iwahori,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, Scientific reports, Vol. 9, No. 1, p. 2447-2447, 2019/02/21
  • Ficolin-1 is a promising therapeutic target for autoimmune diseases., Michihito Katayama,Kaori Ota,Noriko Nagi-Miura,Naohito Ohno,Norikazu Yabuta,Hiroshi Nojima,Atsushi Kumanogoh,Toru Hirano, International immunology, Vol. 31, No. 1, p. 23-32, 2019/02/06
  • Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity., Takeshi Tsuda,Yohei Maeda,Masayuki Nishide,Shohei Koyama,Yoshitomo Hayama,Satoshi Nojima,Hyota Takamatsu,Daisuke Okuzaki,Yuhei Kinehara,Yasuhiro Kato,Takeshi Nakatani,Sho Obata,Hitoshi Akazawa,Takashi Shikina,Kazuya Takeda,Masaki Hayama,Hidenori Inohara,Atsushi Kumanogoh, International immunology, Vol. 31, No. 1, p. 33-40, 2019/02/06
  • Phenotypic Analysis of Tumor Tissue-Infiltrating Lymphocytes in Tumor Microenvironment of Bladder Cancer and Upper Urinary Tract Carcinoma., Iwahori K,Shintani Y,Funaki S,Yamamoto Y,Matsumoto M,Yoshida T,Morimoto-Okazawa A,Kawashima A,Sato E,Gottschalk S,Okumura M,Kumanogoh A,Wada H, Sci Rep., Vol. 9, No. 1, p. 2636-2636, 2019/02
  • Clinical Course of Amyloid A Amyloidosis Secondary to Rheumatoid Arthritis Treated with Anti-Rheumatic Drugs Including Biologic Agent: Case Series in Answer Cohort, Hirano T,Maeda Y,Ebina K,Nagai K,Son Y,Amuro H,Hara R,Hashimoto M,Kumanogoh A, Arch Clin Med Case Rep, Vol. 3, No. 6, p. 508-517, 2019
  • Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study., Kosuke Ebina,Motomu Hashimoto,Wataru Yamamoto,Toru Hirano,Ryota Hara,Masaki Katayama,Akira Onishi,Koji Nagai,Yonsu Son,Hideki Amuro,Keiichi Yamamoto,Yuichi Maeda,Koichi Murata,Sadao Jinno,Tohru Takeuchi,Makoto Hirao,Atsushi Kumanogoh,Hideki Yoshikawa, PloS one, Vol. 14, No. 5, 2019
  • PlexinA1 is crucial for the midline crossing of callosal axons during corpus callosum development in BALB/cAJ mice., Md Mosharaf Hossain,Takamasa Tsuzuki,Kazuki Sakakibara,Fumitaka Imaizumi,Akihiro Ikegaya,Mami Inagaki,Ikuko Takahashi,Takuji Ito,Hyota Takamatsu,Atsushi Kumanogoh,Takayuki Negishi,Kazunori Yukawa, PloS one, Vol. 14, No. 8, 2019
  • The Outcomes of Induction Chemoradiotherapy Followed by Surgery for Clinical T3-4 Non-Small Cell Lung Cancer., Ryu Kanzaki,Naoko Ose,Soichiro Funaki,Yasushi Shintani,Masato Minami,Osamu Suzuki,Hiroshi Kida,Kazuhiko Ogawa,Atsushi Kumanogoh,Meinoshin Okumura, Technology in cancer research & treatment, Vol. 18, p. 1533033819871327-1533033819871327, 2019/01/01
  • Development and validation of a deep-learning model for scoring of radiographic finger joint destruction in rheumatoid arthritis., Toru Hirano,Masayuki Nishide,Naoki Nonaka,Jun Seita,Kosuke Ebina,Kazuhiro Sakurada,Atsushi Kumanogoh, Rheumatology advances in practice, Vol. 3, No. 2, 2019
  • Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer., Takuya Shintani,Kazuma Higashisaka,Makiko Maeda,Masaya Hamada,Ryosuke Tsuji,Koudai Kurihara,Yuri Kashiwagi,Atsuhiro Sato,Masanori Obana,Ayaha Yamamoto,Keisuke Kawasaki,Ying Lin,Takashi Kijima,Yuhei Kinehara,Yoshihiro Miwa,Shinichiro Maeda,Eiichi Morii,Atsushi Kumanogoh,Yasuo Tsutsumi,Izumi Nagatomo,Yasushi Fujio, Oncotarget, Vol. 9, No. 101, p. 37520-37533, 2018/12/25
  • Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells., Yuhei Kinehara,Izumi Nagatomo,Shohei Koyama,Daisuke Ito,Satoshi Nojima,Ryota Kurebayashi,Yoshimitsu Nakanishi,Yasuhiko Suga,Yu Nishijima-Futami,Akio Osa,Takeshi Nakatani,Yasuhiro Kato,Masayuki Nishide,Yoshitomo Hayama,Masayoshi Higashiguchi,Osamu Morimura,Kotaro Miyake,Sujin Kang,Toshiyuki Minami,Haruhiko Hirata,Kota Iwahori,Takayuki Takimoto,Hyota Takamatsu,Yoshito Takeda,Naoki Hosen,Shigenori Hoshino,Yasushi Shintani,Meinoshin Okumura,Toru Kumagai,Kazumi Nishino,Fumio Imamura,Shin-Ichi Nakatsuka,Takashi Kijima,Hiroshi Kida,Atsushi Kumanogoh, JCI insight, Vol. 3, No. 24, 2018/12/20
  • Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity., Saori Sakaue,Jun Hirata,Yuichi Maeda,Eiryo Kawakami,Takuro Nii,Toshihiro Kishikawa,Kazuyoshi Ishigaki,Chikashi Terao,Ken Suzuki,Masato Akiyama,Naomasa Suita,Tatsuo Masuda,Kotaro Ogawa,Kenichi Yamamoto,Yukihiko Saeki,Masato Matsushita,Maiko Yoshimura,Hidetoshi Matsuoka,Katsunori Ikari,Atsuo Taniguchi,Hisashi Yamanaka,Hideya Kawaji,Timo Lassmann,Masayoshi Itoh,Hiroyuki Yoshitomi,Hiromu Ito,Koichiro Ohmura,Alistair R R Forrest,Yoshihide Hayashizaki,Piero Carninci,Atsushi Kumanogoh,Yoichiro Kamatani,Michiel de Hoon,Kazuhiko Yamamoto,Yukinori Okada, Nucleic acids research, Vol. 46, No. 22, p. 11898-11909, 2018/12/14
  • Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides., Jun Nakata,Hiroko Nakajima,Hiromu Hayashibara,Kanako Imafuku,Soyoko Morimoto,Fumihiro Fujiki,Daisuke Motooka,Daisuke Okuzaki,Kana Hasegawa,Naoki Hosen,Akihiro Tsuboi,Yoshihiro Oka,Atsushi Kumanogoh,Yusuke Oji,Haruo Sugiyama, Oncotarget, Vol. 9, No. 89, p. 36029-36038, 2018/11/13
  • Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients., Akio Osa,Takeshi Uenami,Shohei Koyama,Kosuke Fujimoto,Daisuke Okuzaki,Takayuki Takimoto,Haruhiko Hirata,Yukihiro Yano,Soichiro Yokota,Yuhei Kinehara,Yujiro Naito,Tomoyuki Otsuka,Masaki Kanazu,Muneyoshi Kuroyama,Masanari Hamaguchi,Taro Koba,Yu Futami,Mikako Ishijima,Yasuhiko Suga,Yuki Akazawa,Hirotomo Machiyama,Kota Iwahori,Hyota Takamatsu,Izumi Nagatomo,Yoshito Takeda,Hiroshi Kida,Esra A Akbay,Peter S Hammerman,Kwok-Kin Wong,Glenn Dranoff,Masahide Mori,Takashi Kijima,Atsushi Kumanogoh, JCI insight, Vol. 3, No. 19, 2018/10/04
  • The Direct Oblique Method: A New Gold Standard for Bronchoscopic Navigation That is Superior to Automatic Methods., Kotaro Miyake,Osamu Morimura,Takako Inoue,Kenya Yoshida,Izumi Nagatomo,Takashi Kijima,Atsushi Kumanogoh, Journal of bronchology & interventional pulmonology, Vol. 25, No. 4, p. 305-314, 2018/10
  • Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus., Yasuhiro Kato,JeongHoon Park,Hyota Takamatsu,Hachirou Konaka,Wataru Aoki,Syunsuke Aburaya,Mitsuyoshi Ueda,Masayuki Nishide,Shohei Koyama,Yoshitomo Hayama,Yuhei Kinehara,Toru Hirano,Yoshihito Shima,Masashi Narazaki,Atsushi Kumanogoh, Annals of the rheumatic diseases, Vol. 77, No. 10, p. 1507-1515, 2018/10
  • Minimal neonatal transfer of certolizumab pegol in a Japanese patient with rheumatoid arthritis., Takayoshi Morita,Kosuke Fujimoto,Yoshihito Shima,Atsushi Ogata,Atsushi Kumanogoh, Annals of the rheumatic diseases, Vol. 77, No. 9, 2018/09
  • Selecting suitable chemotherapies for PD-1/PD-L1 blockade to optimize the tumor immune microenvironment., Shohei Koyama,Izumi Nagatomo,Takashi Kijima,Atsushi Kumanogoh, Oncotarget, Vol. 9, No. 66, p. 32552-32553, 2018/08/24
  • In vivo visualisation of different modes of action of biological DMARDs inhibiting osteoclastic bone resorption., Yoshinobu Matsuura,Junichi Kikuta,Yuika Kishi,Tetsuo Hasegawa,Daisuke Okuzaki,Toru Hirano,Masafumi Minoshima,Kazuya Kikuchi,Atsushi Kumanogoh,Masaru Ishii, Annals of the rheumatic diseases, Vol. 77, No. 8, p. 1219-1225, 2018/08
  • Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse., Jun Nakata,Yoshiki Nakae,Manabu Kawakami,Soyoko Morimoto,Daisuke Motooka,Naoki Hosen,Fumihiro Fujiki,Hiroko Nakajima,Kana Hasegawa,Sumiyuki Nishida,Akihiro Tsuboi,Yusuke Oji,Yoshihiro Oka,Atsushi Kumanogoh,Haruo Sugiyama, British journal of haematology, Vol. 182, No. 2, p. 287-290, 2018/07
  • WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies., Yusuke Oji,Masayoshi Inoue,Yoshito Takeda,Naoki Hosen,Yasushi Shintani,Manabu Kawakami,Takuya Harada,Yui Murakami,Miki Iwai,Mari Fukuda,Sumiyuki Nishida,Jun Nakata,Yoshiki Nakae,Satoshi Takashima,Toshiaki Shirakata,Hiroko Nakajima,Kana Hasegawa,Hiroshi Kida,Takashi Kijima,Soyoko Morimoto,Fumihiro Fujiki,Akihiro Tsuboi,Eiichi Morii,Satoshi Morita,Junichi Sakamoto,Atsushi Kumanogoh,Yoshihiro Oka,Meinoshin Okumura,Haruo Sugiyama, International journal of cancer, Vol. 142, No. 11, p. 2375-2382, 2018/06/01
  • Lysosomal Protein Lamtor1 Controls Innate Immune Responses via Nuclear Translocation of Transcription Factor EB., Yoshitomo Hayama,Tetsuya Kimura,Yoshito Takeda,Shigeyuki Nada,Shohei Koyama,Hyota Takamatsu,Sujin Kang,Daisuke Ito,Yohei Maeda,Masayuki Nishide,Satoshi Nojima,Hana Sarashina-Kida,Takashi Hosokawa,Yuhei Kinehara,Yasuhiro Kato,Takeshi Nakatani,Yoshimitsu Nakanishi,Takeshi Tsuda,Taro Koba,Masato Okada,Atsushi Kumanogoh, Journal of immunology (Baltimore, Md. : 1950), Vol. 200, No. 11, p. 3790-3800, 2018/06/01
  • Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization., Sujin Kang,Yoshimitsu Nakanishi,Yoshiyuki Kioi,Daisuke Okuzaki,Tetsuya Kimura,Hyota Takamatsu,Shohei Koyama,Satoshi Nojima,Masayuki Nishide,Yoshitomo Hayama,Yuhei Kinehara,Yasuhiro Kato,Takeshi Nakatani,Tomomi Shimogori,Junichi Takagi,Toshihiko Toyofuku,Atsushi Kumanogoh, Nature immunology, Vol. 19, No. 6, p. 561-570, 2018/06
  • Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder., Kazuya Yamashita,Makoto Kinoshita,Katsuichi Miyamoto,Akiko Namba,Mikito Shimizu,Toru Koda,Tomoyuki Sugimoto,Yuki Mori,Yoshichika Yoshioka,Yuji Nakatsuji,Atsushi Kumanogoh,Susumu Kusunoki,Hideki Mochizuki,Tatsusada Okuno, Journal of neuroinflammation, Vol. 15, No. 1, p. 125-125, 2018/04/27
  • Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging., Yingji Jin,Yoshito Takeda,Yasushi Kondo,Lokesh P Tripathi,Sujin Kang,Hikari Takeshita,Hanako Kuhara,Yohei Maeda,Masayoshi Higashiguchi,Kotaro Miyake,Osamu Morimura,Taro Koba,Yoshitomo Hayama,Shohei Koyama,Kaori Nakanishi,Takeo Iwasaki,Satoshi Tetsumoto,Kazuyuki Tsujino,Muneyoshi Kuroyama,Kota Iwahori,Haruhiko Hirata,Takayuki Takimoto,Mayumi Suzuki,Izumi Nagatomo,Ken Sugimoto,Yuta Fujii,Hiroshi Kida,Kenji Mizuguchi,Mari Ito,Takashi Kijima,Hiromi Rakugi,Eisuke Mekada,Isao Tachibana,Atsushi Kumanogoh, Scientific reports, Vol. 8, No. 1, p. 5145-5145, 2018/03/23
  • Tracheobronchopathia Osteochondroplastica: A Cause of Difficult Tracheal Intubation., Takanori Matsuki,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, Internal medicine (Tokyo, Japan), Vol. 57, No. 6, p. 909-910, 2018/03/15
  • Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study., Sumiyuki Nishida,Takeshi Ishikawa,Shinichi Egawa,Shigeo Koido,Hiroaki Yanagimoto,Jun Ishii,Yoshihide Kanno,Satoshi Kokura,Hiroaki Yasuda,Mari Saito Oba,Maho Sato,Soyoko Morimoto,Fumihiro Fujiki,Hidetoshi Eguchi,Hiroaki Nagano,Atsushi Kumanogoh,Michiaki Unno,Masanori Kon,Hideaki Shimada,Kei Ito,Sadamu Homma,Yoshihiro Oka,Satoshi Morita,Haruo Sugiyama, Cancer immunology research, Vol. 6, No. 3, p. 320-331, 2018/03
  • Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma., Yoshiko Takeuchi,Atsushi Tanemura,Yasuko Tada,Ichiro Katayama,Atsushi Kumanogoh,Hiroyoshi Nishikawa, International immunology, Vol. 30, No. 1, p. 13-22, 2018/02/03
  • Roles of Lamtor1 in Macrophages, CD4+ T-cells, and Regulatory T-cells., Tetsuya Kimura,Atsushi Kumanogoh,Masato Okada, Critical reviews in immunology, Vol. 38, No. 5, p. 403-414, 2018
  • Beneficial effects of fingolimod in MS patients with high serum Sema4A levels., Toru Koda,Akiko Namba,Yuji Nakatsuji,Masaaki Niino,Yusei Miyazaki,Tomoyuki Sugimoto,Makoto Kinoshita,Kazushiro Takata,Kazuya Yamashita,Mikito Shimizu,Toshiyuki Fukazawa,Atsushi Kumanogoh,Hideki Mochizuki,Tatsusada Okuno, PloS one, Vol. 13, No. 3, 2018
  • Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study., Kosuke Ebina,Motomu Hashimoto,Wataru Yamamoto,Akira Ohnishi,Daijiro Kabata,Toru Hirano,Ryota Hara,Masaki Katayama,Shuzo Yoshida,Koji Nagai,Yonsu Son,Hideki Amuro,Kengo Akashi,Takanori Fujimura,Makoto Hirao,Keiichi Yamamoto,Ayumi Shintani,Atsushi Kumanogoh,Hideki Yoshikawa, PloS one, Vol. 13, No. 3, 2018
  • The role of semaphorins in immune responses and autoimmune rheumatic diseases., Masayuki Nishide,Atsushi Kumanogoh, Nature reviews. Rheumatology, Vol. 14, No. 1, p. 19-31, 2018/01
  • Quantitative pulmonary blood flow measurement using 15O-H2O PET with and without tissue fraction correction: a comparison study., Keiko Matsunaga,Masahiro Yanagawa,Tomoyuki Otsuka,Haruhiko Hirata,Takashi Kijima,Atsushi Kumanogoh,Noriyuki Tomiyama,Eku Shimosegawa,Jun Hatazawa, EJNMMI research, Vol. 7, No. 1, p. 102-102, 2017/12/22
  • Screening of causative genes for fibrosis development in mice, Kiyoharu Fukushima,Takashi Satoh,Atsushi Kumanogoh,Shizuo Akira, 2017/12
  • The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy., Naoki Hosen,Yukiko Matsunaga,Kana Hasegawa,Hiroshi Matsuno,Yuki Nakamura,Mio Makita,Kouki Watanabe,Mikako Yoshida,Kei Satoh,Soyoko Morimoto,Fumihiro Fujiki,Hiroko Nakajima,Jun Nakata,Sumiyuki Nishida,Akihiro Tsuboi,Yoshihiro Oka,Masahiro Manabe,Hiroyoshi Ichihara,Yasutaka Aoyama,Atsuko Mugitani,Takafumi Nakao,Masayuki Hino,Ryosuke Uchibori,Keiya Ozawa,Yoshihiro Baba,Seitaro Terakura,Naoki Wada,Eiichi Morii,Junichi Nishimura,Kiyoshi Takeda,Yusuke Oji,Haruo Sugiyama,Junichi Takagi,Atsushi Kumanogoh, Nature medicine, Vol. 23, No. 12, p. 1436-1443, 2017/12
  • Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis., Hana Sarashina-Kida,Hideo Negishi,Junko Nishio,Wataru Suda,Yuki Nakajima,Mika Yasui-Kato,Keiko Iwaisako,Sujin Kang,Nobuyasu Endo,Hideyuki Yanai,Masataka Asagiri,Hiroshi Kida,Masahira Hattori,Atsushi Kumanogoh,Tadatsugu Taniguchi, Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 38, p. 10178-10183, 2017/09/19
  • Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive Function., Takashi Hosokawa,Tetsuya Kimura,Shigeyuki Nada,Tatsusada Okuno,Daisuke Ito,Sujin Kang,Satoshi Nojima,Kazuya Yamashita,Takeshi Nakatani,Yoshitomo Hayama,Yasuhiro Kato,Yuhei Kinehara,Masayuki Nishide,Norihisa Mikami,Syohei Koyama,Hyota Takamatsu,Daisuke Okuzaki,Naganari Ohkura,Shimon Sakaguchi,Masato Okada,Atsushi Kumanogoh, Journal of immunology (Baltimore, Md. : 1950), Vol. 199, No. 6, p. 2008-2019, 2017/09/15
  • Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study., Takayuki Shiroyama,Motohiro Tamiya,Seigo Minami,So Takata,Kentaro Masuhiro,Yu Futami-Nishijima,Takeshi Uenami,Masahide Mori,Taro Koba,Takanori Matsuki,Takayuki Takimoto,Hidekazu Suzuki,Norio Okamoto,Kiyoshi Komuta,Tomonori Hirashima,Atsushi Kumanogoh,Takashi Kijima, Cancer chemotherapy and pharmacology, Vol. 80, No. 3, p. 461-467, 2017/09
  • CUBIC pathology: three-dimensional imaging for pathological diagnosis., Satoshi Nojima,Etsuo A Susaki,Kyotaro Yoshida,Hiroyoshi Takemoto,Naoto Tsujimura,Shohei Iijima,Ko Takachi,Yujiro Nakahara,Shinichiro Tahara,Kenji Ohshima,Masako Kurashige,Yumiko Hori,Naoki Wada,Jun-Ichiro Ikeda,Atsushi Kumanogoh,Eiichi Morii,Hiroki R Ueda, Scientific reports, Vol. 7, No. 1, p. 9269-9269, 2017/08/24
  • Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade., Esra A Akbay,Shohei Koyama,Yan Liu,Ruben Dries,Lauren E Bufe,Michael Silkes,Md Maksudul Alam,Dillon M Magee,Robert Jones,Masahisa Jinushi,Meghana Kulkarni,Julian Carretero,Xiaoen Wang,Tiquella Warner-Hatten,Jillian D Cavanaugh,Akio Osa,Atsushi Kumanogoh,Gordon J Freeman,Mark M Awad,David C Christiani,Raphael Bueno,Peter S Hammerman,Glenn Dranoff,Kwok-Kin Wong, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Vol. 12, No. 8, p. 1268-1279, 2017/08
  • Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis., Masayuki Nishide,Satoshi Nojima,Daisuke Ito,Hyota Takamatsu,Shohei Koyama,Sujin Kang,Tetsuya Kimura,Keiko Morimoto,Takashi Hosokawa,Yoshitomo Hayama,Yuhei Kinehara,Yasuhiro Kato,Takeshi Nakatani,Yoshimitsu Nakanishi,Takeshi Tsuda,Jeong Hoon Park,Toru Hirano,Yoshihito Shima,Masashi Narazaki,Eiichi Morii,Atsushi Kumanogoh, Annals of the rheumatic diseases, Vol. 76, No. 8, p. 1440-1448, 2017/08
  • Control of species-dependent cortico-motoneuronal connections underlying manual dexterity., Zirong Gu,John Kalambogias,Shin Yoshioka,Wenqi Han,Zhuo Li,Yuka Imamura Kawasawa,Sirisha Pochareddy,Zhen Li,Fuchen Liu,Xuming Xu,H. R. Sagara Wijeratne,Masaki Ueno,Emily Blatz,Joseph Salomone,Atsushi Kumanogoh,Mladen-Roko Rasin,Brian Gebelein,Matthew T Weirauch,Nenad Sestan,John H Martin,Yutaka Yoshida, Science (New York, N.Y.), Vol. 357, No. 6349, p. 400-404, 2017/07/28
  • Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models., Osamu Morimura,Toshiyuki Minami,Takashi Kijima,Shohei Koyama,Tomoyuki Otsuka,Yuhei Kinehara,Akio Osa,Masayoshi Higashiguchi,Kotaro Miyake,Izumi Nagatomo,Haruhiko Hirata,Kota Iwahori,Takayuki Takimoto,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, Biochemical and biophysical research communications, Vol. 488, No. 4, p. 596-602, 2017/07/08
  • Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas database, Higashiguchi Masayoshi,Nagatomo Izumi,Kijima Takashi,Morimura Osamu,Miyake Kotaro,Minami Toshiyuki,Koyama Shohei,Hirata Haruhiko,Iwahori Kota,Takimoto Takayuki,Takeda Yoshito,Kida Hiroshi,Kumanogoh Atsushi, CANCER RESEARCH, Vol. 77, 2017/07
  • 線維症における新規のマクロファージサブタイプの同定, 福島 清春,佐藤 荘,熊ノ郷 淳,審良 静男, 2017/06
  • Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease., Takeharu Minamitani,Yijie Ma,Hufeng Zhou,Hiroshi Kida,Chao-Yuan Tsai,Masanori Obana,Daisuke Okuzaki,Yasushi Fujio,Atsushi Kumanogoh,Bo Zhao,Hitoshi Kikutani,Elliott Kieff,Benjamin E Gewurz,Teruhito Yasui, Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 18, p. 4751-4756, 2017/05/02
  • BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection., Shoko Kitada,Hisako Kayama,Daisuke Okuzaki,Ritsuko Koga,Masao Kobayashi,Yasunobu Arima,Atsushi Kumanogoh,Masaaki Murakami,Masahito Ikawa,Kiyoshi Takeda, The Journal of experimental medicine, Vol. 214, No. 5, p. 1313-1331, 2017/05/01
  • Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186., Kosuke Fujimoto,Makoto Kinoshita,Hiroo Tanaka,Daisuke Okuzaki,Yosuke Shimada,Hisako Kayama,Ryu Okumura,Yoki Furuta,Masashi Narazaki,Atsushi Tamura,Shigetsugu Hatakeyama,Masahito Ikawa,Kiichiro Tsuchiya,Mamoru Watanabe,Atsushi Kumanogoh,Sachiko Tsukita,Kiyoshi Takeda, Mucosal Immunol, Vol. 10, No. 2, p. 446-459, 2017/03
  • Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186., Kosuke Fujimoto,Makoto Kinoshita,Hiroo Tanaka,Daisuke Okuzaki,Yosuke Shimada,Hisako Kayama,Ryu Okumura,Yoki Furuta,Masashi Narazaki,Atsushi Tamura,Shigetsugu Hatakeyama,Masahito Ikawa,Kiichiro Tsuchiya,Mamoru Watanabe,Atsushi Kumanogoh,Sachiko Tsukita,Kiyoshi Takeda, Mucosal immunology, Vol. 10, No. 2, p. 446-459, 2017/03
  • Erratum: Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals., Tetsuya Kimura,Shigeyuki Nada,Noriko Takegahara,Tatsusada Okuno,Satoshi Nojima,Sujin Kang,Daisuke Ito,Keiko Morimoto,Takashi Hosokawa,Yoshitomo Hayama,Yuichi Mitsui,Natsuki Sakurai,Hana Sarashina-Kida,Masayuki Nishide,Yohei Maeda,Hyota Takamatsu,Daisuke Okuzaki,Masaki Yamada,Masato Okada,Atsushi Kumanogoh, Nature communications, Vol. 8, p. 14711-14711, 2017/02/27
  • Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibody., Yoshimasa Hamano,Hiroshi Kida,Shoichi Ihara,Akihiro Murakami,Masahiro Yanagawa,Ken Ueda,Osamu Honda,Lokesh P Tripathi,Toru Arai,Masaki Hirose,Toshimitsu Hamasaki,Yukihiro Yano,Tetsuya Kimura,Yasuhiro Kato,Hyota Takamatsu,Tomoyuki Otsuka,Toshiyuki Minami,Haruhiko Hirata,Koji Inoue,Izumi Nagatomo,Yoshito Takeda,Masahide Mori,Hiroyoshi Nishikawa,Kenji Mizuguchi,Takashi Kijima,Masanori Kitaichi,Noriyuki Tomiyama,Yoshikazu Inoue,Atsushi Kumanogoh, Scientific reports, Vol. 7, p. 43201-43201, 2017/02/23
  • Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports., Taro Koba,Takashi Kijima,Takayuki Takimoto,Haruhiko Hirata,Yujiro Naito,Masanari Hamaguchi,Tomoyuki Otsuka,Muneyoshi Kuroyama,Izumi Nagatomo,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, Medicine, Vol. 96, No. 6, 2017/02
  • Identification of an atypical monocyte and committed progenitor involved in fibrosis., Takashi Satoh,Katsuhiro Nakagawa,Fuminori Sugihara,Ryusuke Kuwahara,Motooki Ashihara,Fumihiro Yamane,Yosuke Minowa,Kiyoharu Fukushima,Isao Ebina,Yoshichika Yoshioka,Atsushi Kumanogoh,Shizuo Akira, Nature, Vol. 541, No. 7635, p. 96-101, 2017/01/05
  • Serum anti-citrullinated protein antibodies of a mother with rheumatoid arthritis pass through the placenta but do not cause arthritis in her neonate, T. Morita,Y. Shima,A. Kakigano,A. Ogata,A. Kumanogoh, SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, TAYLOR & FRANCIS LTD, Vol. 46, No. 1, p. 85-86, 2017
  • アレルギー学からみた内科疾患:病態解明から新規治療の開発へ、司会者のことば, 楠 進,熊ノ郷 淳, 日本内科学会雑誌, Vol. 106, 2017
  • Characterizing Semaphorin-Mediated Immune Responses Using an Antigen-Presentation Assay., Satoshi Nojima,Atsushi Kumanogoh, Methods in molecular biology (Clifton, N.J.), Vol. 1493, p. 379-391, 2017
  • Fungal ITS1 Deep-Sequencing Strategies to Reconstruct the Composition of a 26-Species Community and Evaluation of the Gut Mycobiota of Healthy Japanese Individuals., Daisuke Motooka,Kosuke Fujimoto,Reiko Tanaka,Takashi Yaguchi,Kazuyoshi Gotoh,Yuichi Maeda,Yoki Furuta,Takashi Kurakawa,Naohisa Goto,Teruo Yasunaga,Masashi Narazaki,Atsushi Kumanogoh,Toshihiro Horii,Tetsuya Iida,Kiyoshi Takeda,Shota Nakamura, Frontiers in microbiology, Vol. 8, p. 238-238, 2017
  • Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy., Yoshihiro Oka,Akihiro Tsuboi,Jun Nakata,Sumiyuki Nishida,Naoki Hosen,Atsushi Kumanogoh,Yusuke Oji,Haruo Sugiyama, Oncology research and treatment, Vol. 40, No. 11, p. 682-690, 2017
  • Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner., Josephe A Honorat,Yuji Nakatsuji,Mikito Shimizu,Makoto Kinoshita,Hisae Sumi-Akamaru,Tsutomu Sasaki,Kazushiro Takata,Toru Koda,Akiko Namba,Kazuya Yamashita,Eri Sanda,Manabu Sakaguchi,Atsushi Kumanogoh,Takashi Shirakura,Mizuho Tamura,Saburo Sakoda,Hideki Mochizuki,Tatsusada Okuno, PloS one, Vol. 12, No. 11, 2017
  • Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas database., Masayoshi Higashiguchi,Izumi Nagatomo,Takashi Kijima,Osamu Morimura,Kotaro Miyake,Toshiyuki Minami,Shohei Koyama,Haruhiko Hirata,Kota Iwahori,Takayuki Takimoto,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, FEBS letters, Vol. 590, No. 23, p. 4275-4286, 2016/12
  • Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine., Satoshi Takashima,Yoshihiro Oka,Fumihiro Fujiki,Soyoko Morimoto,Hiroko Nakajima,Yoshiki Nakae,Jun Nakata,Sumiyuki Nishida,Naoki Hosen,Naoya Tatsumi,Kenji Mizuguchi,Naoya Hashimoto,Yusuke Oji,Akihiro Tsuboi,Atsushi Kumanogoh,Haruo Sugiyama, Future science OA, Vol. 2, No. 4, 2016/12
  • CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis., Kotaro Miyake,Toshio Ohta,Hisako Nakayama,Nobutaka Doe,Yuri Terao,Eiji Oiki,Izumi Nagatomo,Yui Yamashita,Takaya Abe,Kazuko Nishikura,Atsushi Kumanogoh,Kouichi Hashimoto,Yukio Kawahara, Cell reports, Vol. 17, No. 8, p. 2004-2014, 2016/11/15
  • The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems., Daisuke Ito,Atsushi Kumanogoh, Cell adhesion & migration, Vol. 10, No. 6, p. 692-699, 2016/11
  • Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine., Yuichi Maeda,Takashi Kurakawa,Eiji Umemoto,Daisuke Motooka,Yoshinaga Ito,Kazuyoshi Gotoh,Keiji Hirota,Masato Matsushita,Yoki Furuta,Masashi Narazaki,Noriko Sakaguchi,Hisako Kayama,Shota Nakamura,Tetsuya Iida,Yukihiko Saeki,Atsushi Kumanogoh,Shimon Sakaguchi,Kiyoshi Takeda, Arthritis & rheumatology (Hoboken, N.J.), Vol. 68, No. 11, p. 2646-2661, 2016/11
  • Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals., Tetsuya Kimura,Shigeyuki Nada,Noriko Takegahara,Tatsusada Okuno,Satoshi Nojima,Sujin Kang,Daisuke Ito,Keiko Morimoto,Takashi Hosokawa,Yoshitomo Hayama,Yuichi Mitsui,Natsuki Sakurai,Hana Sarashina-Kida,Masayuki Nishide,Yohei Maeda,Hyota Takamatsu,Daisuke Okuzaki,Masaki Yamada,Masato Okada,Atsushi Kumanogoh, Nature communications, Vol. 7, p. 13130-13130, 2016/10/12
  • [113th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Insight into the Mechanism of Diseases on New Perspective Arising in Internal Medicine: From Epigenetics to Organ Associations: A New Perspective in the Regulation of Immune System -With a Focus on Semaphorins and Immune-metabolism]., Daisuke Ito,Atsushi Kumanogoh, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, Vol. 105, No. 9, p. 1732-8, 2016/09
  • LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation., Keiko Morimoto,Yoshihiro Baba,Hisaaki Shinohara,Sujin Kang,Satoshi Nojima,Tetsuya Kimura,Daisuke Ito,Yuji Yoshida,Yohei Maeda,Hana Sarashina-Kida,Masayuki Nishide,Takashi Hosokawa,Yasuhiro Kato,Yoshitomo Hayama,Yuhei Kinehara,Tatsusada Okuno,Hyota Takamatsu,Toru Hirano,Yoshihito Shima,Masashi Narazaki,Tomohiro Kurosaki,Toshihiko Toyofuku,Atsushi Kumanogoh, Scientific reports, Vol. 6, p. 25738-25738, 2016/05/11
  • Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis., Yuhsuke Ohmi,Wataru Ise,Akira Harazono,Daisuke Takakura,Hidehiro Fukuyama,Yoshihiro Baba,Masashi Narazaki,Hirofumi Shoda,Nobunori Takahashi,Yuki Ohkawa,Shuting Ji,Fumihiro Sugiyama,Keishi Fujio,Atsushi Kumanogoh,Kazuhiko Yamamoto,Nana Kawasaki,Tomohiro Kurosaki,Yoshimasa Takahashi,Koichi Furukawa, Nature communications, Vol. 7, p. 11205-11205, 2016/04/05
  • LRRK1 plays an essential role in B-cell responses by regulating BCR-dependent NF-kappa B signaling, Morimoto, K.,Baba, Y.,Shinohara, H.,Kurosaki, T.,Toyofuku, T.,Kumanogoh, A., European Journal of Immunology, Vol. 46, p. 847-848, 2016
  • Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis., Kana Hasegawa,Satomi Tanaka,Fumihiro Fujiki,Soyoko Morimoto,Katsuhiko Nakano,Hiroko Kinoshita,Atsushi Okumura,Yuka Fujioka,Rika Urakawa,Hiroko Nakajima,Naoya Tatsumi,Jun Nakata,Satoshi Takashima,Sumiyuki Nishida,Akihiro Tsuboi,Yoshihiro Oka,Yusuke Oji,Eiji Miyoshi,Takako Hirata,Atsushi Kumanogoh,Haruo Sugiyama,Naoki Hosen, PloS one, Vol. 11, No. 3, 2016
  • Altered composition of gut microbiota in rheumatoid arthritis patients., Yuichi Maeda,Atsushi Kumanogoh,Kiyoshi Takeda, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, Vol. 39, No. 1, p. 59-63, 2016
  • Structure of the Plexin Ectodomain Bound by Semaphorin-Mimicking Antibodies., Kei Suzuki,Hiroyuki Tsunoda,Ryusuke Omiya,Kyoko Matoba,Takeshi Baba,Sachiyo Suzuki,Hiroaki Segawa,Atsushi Kumanogoh,Kenji Iwasaki,Kunihiro Hattori,Junichi Takagi, PloS one, Vol. 11, No. 6, 2016
  • The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis., Takayoshi Morita,Yoshihito Shima,James Badger Wing,Shimon Sakaguchi,Atsushi Ogata,Atsushi Kumanogoh, PloS one, Vol. 11, No. 9, 2016
  • [Semaphorins as treatment targets for cartilage and bone damage caused by rheumatoid arthritis]., Yuji Yoshida,Atsushi Kumanogoh, Clinical calcium, Vol. 25, No. 12, p. 1795-800, 2015/12
  • Optimization of Treatment Intervals of Tocilizumab and Golimumab By Measuring Serum Trough Levels in Rheumatoid Arthritis Patients, Yoshinobu Matsuura,Masashi Narazaki,Masayuki Nishide,Yasuhiro Kato,Hideki Yorifuji,Toru Hirano,Yoshihito Shima,Toshio Tanaka,Atsushi Ogata,Atsushi Kumanogoh, ARTHRITIS & RHEUMATOLOGY, WILEY-BLACKWELL, Vol. 67, p. 815-816, 2015/10
  • Leucine-Rich Repeat Kinase 1 Regulates Autophagy through Turning On TBC1D2-Dependent Rab7 Inactivation., Toshihiko Toyofuku,Keiko Morimoto,Shigemi Sasawatari,Atsushi Kumanogoh, Molecular and cellular biology, Vol. 35, No. 17, p. 3044-58, 2015/09/01
  • mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells., Daisuke Ito,Satoshi Nojima,Masayuki Nishide,Tatsusada Okuno,Hyota Takamatsu,Sujin Kang,Tetsuya Kimura,Yuji Yoshida,Keiko Morimoto,Yohei Maeda,Takashi Hosokawa,Toshihiko Toyofuku,Jun Ohshima,Daisuke Kamimura,Masahiro Yamamoto,Masaaki Murakami,Eiichi Morii,Hiromi Rakugi,Yoshitaka Isaka,Atsushi Kumanogoh, Journal of immunology (Baltimore, Md. : 1950), Vol. 195, No. 3, p. 934-43, 2015/08/01
  • Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients., Yoshiki Nakae,Yoshihiro Oka,Fumihiro Fujiki,Soyoko Morimoto,Toshio Kamiya,Satoshi Takashima,Jun Nakata,Sumiyuki Nishida,Hiroko Nakajima,Naoki Hosen,Akihiro Tsuboi,Taiichi Kyo,Yusuke Oji,Kenji Mizuguchi,Atsushi Kumanogoh,Haruo Sugiyama, Cancer immunology, immunotherapy : CII, Vol. 64, No. 7, p. 791-804, 2015/07
  • Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications., Yuji Yoshida,Atsushi Ogata,Sujin Kang,Kousuke Ebina,Kenrin Shi,Satoshi Nojima,Tetsuya Kimura,Daisuke Ito,Keiko Morimoto,Masayuki Nishide,Takashi Hosokawa,Toru Hirano,Yoshihito Shima,Masashi Narazaki,Hideki Tsuboi,Yukihiko Saeki,Tetsuya Tomita,Toshio Tanaka,Atsushi Kumanogoh, Arthritis & rheumatology (Hoboken, N.J.), Vol. 67, No. 6, p. 1481-90, 2015/06
  • Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension., Takahiro Hashimoto-Kataoka,Naoki Hosen,Takashi Sonobe,Yoh Arita,Taku Yasui,Takeshi Masaki,Masato Minami,Tadakatsu Inagaki,Shigeru Miyagawa,Yoshiki Sawa,Masaaki Murakami,Atsushi Kumanogoh,Keiko Yamauchi-Takihara,Meinoshin Okumura,Tadamitsu Kishimoto,Issei Komuro,Mikiyasu Shirai,Yasushi Sakata,Yoshikazu Nakaoka, Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 20, p. E2677-86-86, 2015/05/19
  • Semaphorin-Plexin Signaling Controls Mitotic Spindle Orientation during Epithelial Morphogenesis and Repair., Jingjing Xia,Jakub M Swiercz,Inmaculada Bañón-Rodríguez,Ivana Matković,Giuseppina Federico,Tianliang Sun,Timo Franz,Cord H Brakebusch,Atsushi Kumanogoh,Roland H Friedel,Fernando Martín-Belmonte,Hermann-Josef Gröne,Stefan Offermanns,Thomas Worzfeld, Developmental cell, Vol. 33, No. 3, p. 299-313, 2015/05/04
  • CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy., Hirotsugu Iwatani,Yasuyuki Nagasawa,Ryohei Yamamoto,Kenichiro Iio,Masayuki Mizui,Arata Horii,Tadashi Kitahara,Hidenori Inohara,Atsushi Kumanogoh,Enyu Imai,Hiromi Rakugi,Yoshitaka Isaka, Clinical and experimental nephrology, Vol. 19, No. 2, p. 216-24, 2015/04
  • Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer., Yuhei Kinehara,Toshiyuki Minami,Takashi Kijima,Shigenori Hoshino,Osamu Morimura,Tomoyuki Otsuka,Yoshitomo Hayama,Kiyoharu Fukushima,Yoshiko Takeuchi,Masayoshi Higashiguchi,Kotaro Miyake,Haruhiko Hirata,Izumi Nagatomo,Koji Inoue,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, Lung cancer (Amsterdam, Netherlands), Vol. 87, No. 3, p. 321-5, 2015/03
  • CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα., Tatsuki R Kataoka,Atsushi Kumanogoh,Nobuyuki Fukuishi,Chiyuki Ueshima,Masahiro Hirata,Koki Moriyoshi,Tatsuaki Tsuruyama,Hironori Haga, International immunology, Vol. 27, No. 2, p. 95-103, 2015/02
  • Semaphorin 4D induces vaginal epithelial cell apoptosis to control mouse postnatal vaginal tissue remodeling., Takuji Ito,Tao Bai,Tetsuji Tanaka,Kenji Yoshida,Takashi Ueyama,Masayasu Miyajima,Takayuki Negishi,Takahiko Kawasaki,Hyota Takamatsu,Hitoshi Kikutani,Atsushi Kumanogoh,Kazunori Yukawa, Molecular medicine reports, Vol. 11, No. 2, p. 829-36, 2015/02
  • Semaphorins in the immune system, Satoshi Nojima,Atsushi Kumanogoh, Semaphorins: A Diversity of Emerging Physiological and Pathological Activities, Springer Japan, p. 137-158, 2015/01/01
  • Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab., Yoshihito Shima,Naoki Hosen,Toru Hirano,Junsuke Arimitsu,Sumiyuki Nishida,Keisuke Hagihara,Masashi Narazaki,Atsushi Ogata,Toshio Tanaka,Tadamitsu Kishimoto,Atsushi Kumanogoh, Modern rheumatology, Vol. 25, No. 1, p. 134-7, 2015/01
  • Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid., Yuhei Kinehara,Takashi Kijima,Koji Inoue,Haruhiko Hirata,Yoshiko Takeuchi,Kiyoharu Fukushima,Yoshitomo Hayama,Masayoshi Higashiguchi,Osamu Morimura,Kotaro Miyake,Toshiyuki Minami,Izumi Nagatomo,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, Internal medicine (Tokyo, Japan), Vol. 54, No. 7, p. 827-31, 2015
  • An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells., Kana Hasegawa,Satomi Tanaka,Fumihiro Fujiki,Soyoko Morimoto,Hiroko Nakajima,Naoya Tatsumi,Jun Nakata,Satoshi Takashima,Sumiyuki Nishida,Akihiro Tsuboi,Yoshihiro Oka,Yusuke Oji,Atsushi Kumanogoh,Haruo Sugiyama,Naoki Hosen, PloS one, Vol. 10, No. 12, 2015
  • Comprehensive exploration of autoantibody in Behçet's disease: a novel autoantibody to claudin-1, an essential protein for tight junctions, is identified., Atsuyoshi Morishima,Toru Hirano,Hiroyoshi Nishikawa,Kei Nakai,Shimon Sakaguchi,Atsushi Kumanogoh, Joint bone spine, Vol. 81, No. 6, p. 546-8, 2014/12
  • Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis., Yuhei Kinehara,Hiroshi Kida,Yoshikazu Inoue,Masaki Hirose,Akihiko Nakabayashi,Yoshiko Takeuchi,Yoshitomo Hayama,Kiyoharu Fukushima,Haruhiko Hirata,Koji Inoue,Toshiyuki Minami,Izumi Nagatomo,Yoshito Takeda,Toshiki Funakoshi,Takashi Kijima,Atsushi Kumanogoh, BMC pulmonary medicine, Vol. 14, p. 172-172, 2014/11/04
  • Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X., Eduard Schulz,Petra Klampfl,Stefanie Holzapfel,Andreas R Janecke,Peter Ulz,Wilfried Renner,Karl Kashofer,Satoshi Nojima,Anita Leitner,Armin Zebisch,Albert Wölfler,Sybille Hofer,Armin Gerger,Sigurd Lax,Christine Beham-Schmid,Verena Steinke,Ellen Heitzer,Jochen B Geigl,Christian Windpassinger,Gerald Hoefler,Michael R Speicher,C Richard Boland,Atsushi Kumanogoh,Heinz Sill, Nature communications, Vol. 5, p. 5191-5191, 2014/10/13
  • A retrospective study of prognostic factors in patients with interstitial pneumonia receiving long-term oxygen therapy., Masayoshi Higashiguchi,Takashi Kijima,Hiromitsu Sumikawa,Osamu Honda,Toshiyuki Minami,Haruhiko Hirata,Koji Inoue,Izumi Nagatomo,Yoshito Takeda,Hiroshi Kida,Noriyuki Tomiyama,Atsushi Kumanogoh, Lung, Vol. 192, No. 5, p. 729-37, 2014/10
  • Vaccination strategies to improve outcome of hematopoietic stem cell transplant in leukemia patients: early evidence and future prospects., Naoki Hosen,Tetsuo Maeda,Yoshiko Hashii,Akihiro Tsuboi,Sumiyuki Nishida,Jun Nakata,Yoshiki Nakae,Satoshi Takashima,Yusuke Oji,Yoshihiro Oka,Atsushi Kumanogoh,Haruo Sugiyama, Expert review of hematology, Vol. 7, No. 5, p. 671-81, 2014/10
  • In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity, J. Nakata,K. Nakano,A. Okumura,Y. Mizutani,H. Kinoshita,M. Iwai,K. Hasegawa,S. Morimoto,F. Fujiki,N. Tatsumi,H. Nakajima,Y. Nakae,S. Nishida,A. Tsuboi,Y. Oji,Y. Oka,H. Sugiyama,A. Kumanogoh,N. Hosen, LEUKEMIA, NATURE PUBLISHING GROUP, Vol. 28, No. 6, p. 1316-1325, 2014/06
  • Plexin-A1 is required for Toll-like receptor-mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy., Takuji Ito,Kenji Yoshida,Takayuki Negishi,Masayasu Miyajima,Hyota Takamatsu,Hitoshi Kikutani,Atsushi Kumanogoh,Kazunori Yukawa, International journal of molecular medicine, Vol. 33, No. 5, p. 1122-30, 2014/05
  • Sema4A inhibits the therapeutic effect of IFN-β in EAE., Toru Koda,Tatsusada Okuno,Kazushiro Takata,Josephe Archie Honorat,Makoto Kinoshita,Satoru Tada,Masayuki Moriya,Saburo Sakoda,Hideki Mochizuki,Atsushi Kumanogoh,Yuji Nakatsuji, Journal of neuroimmunology, Vol. 268, No. 1-2, p. 43-9, 2014/03/15
  • Wilms Tumor Gene ( WT1) Peptide- based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer, Sumiyuki Nishida,Shigeo Koido,Yutaka Takeda,Sadamu Homma,Hideo Komita,Akitaka Takahara,Satoshi Morita,Toshinori Ito,Soyoko Morimoto,Kazuma Hara,Akihiro Tsuboi,Yoshihiro Oka,Satoru Yanagisawa,Yoichi Toyama,Masahiro Ikegami,Toru Kitagawa,Hidetoshi Eguchi,Hiroshi Wada,Hiroaki Nagano,Jun Nakata,Yoshiki Nakae,Naoki Hosen,Yusuke Oji,Toshio Tanaka,Ichiro Kawase,Atsushi Kumanogoh,Junichi Sakamoto,Yuichiro Doki,Masaki Mori,Toshifumi Ohkusa,Hisao Tajiri,Haruo Sugiyama, JOURNAL OF IMMUNOTHERAPY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 37, No. 2, p. 105-114, 2014/02
  • Protection against colitis by CD100-dependent modulation of intraepithelial gamma delta T lymphocyte function, T. F. Meehan,D. A. Witherden,C-H Kim,K. Sendaydiego,I. Ye,O. Garijo,H. K. Komori,A. Kumanogoh,H. Kikutani,L. Eckmann,W. L. Havran, MUCOSAL IMMUNOLOGY, NATURE PUBLISHING GROUP, Vol. 7, No. 1, p. 134-142, 2014/01
  • Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa., Ayumi Fujii,Masafumi Seki,Masachika Higashiguchi,Isao Tachibana,Atsushi Kumanogoh,Kazunori Tomono, Respiratory medicine case reports, Vol. 12, p. 30-3, 2014
  • Rapidly progressive pneumonia caused by Cryptococcus neoformans in the patient of granulomatosis with polyangiitis., Akihiko Nakabayashi,Masafumi Seki,Toru Hirano,Haruhiko Hirata,Kazunori Tomono,Atsushi Kumanogoh, Respiratory medicine case reports, Vol. 13, p. 13-5, 2014
  • [The role of semaphorin family in immune systems]., Daisuke Ito,Satoshi Nojima,Atsushi Kumanogoh, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, Vol. 37, No. 1, p. 1-10, 2014
  • Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis., Yoshito Takeda,Kazuyuki Tsujino,Takashi Kijima,Atsushi Kumanogoh, Patient preference and adherence, Vol. 8, p. 361-70, 2014
  • Estrogen-dependent proteolytic cleavage of semaphorin 4D and plexin-B1 enhances semaphorin 4D-induced apoptosis during postnatal vaginal remodeling in pubescent mice., Takuji Ito,Tao Bai,Tetsuji Tanaka,Kenji Yoshida,Takashi Ueyama,Masayasu Miyajima,Takayuki Negishi,Takahiko Kawasaki,Hyota Takamatsu,Hitoshi Kikutani,Atsushi Kumanogoh,Kazunori Yukawa, PloS one, Vol. 9, No. 5, 2014
  • A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment, K. Nishino,F. Imamura,S. Morita,M. Mori,K. Komuta,T. Kijima,Y. Namba,T. Kumagai,S. Yamamoto,I. Tachibana,Y. Nakazawa,J. Uchida,S. Minami,R. Takahashi,Y. Yano,T. Okuyama,A. Kumanogoh, Lung Cancer, Vol. 82, No. 2, p. 299-304, 2013/11
  • Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells., Kazuki Shimada,Satoshi Serada,Minoru Fujimoto,Shintaro Nomura,Rie Nakatsuka,Emi Harada,Kota Iwahori,Isao Tachibana,Tsuyoshi Takahashi,Atsushi Kumanogoh,Tadamitsu Kishimoto,Tetsuji Naka, Cancer science, Vol. 104, No. 11, p. 1483-91, 2013/11
  • Immunological functions of the neuropilins and plexins as receptors for semaphorins., Atsushi Kumanogoh,Hitoshi Kikutani, Nature reviews. Immunology, Vol. 13, No. 11, p. 802-14, 2013/11
  • CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1., Tatsuki R Kataoka,Atsushi Kumanogoh,Masahiro Hirata,Koki Moriyoshi,Chiyuki Ueshima,Masahiro Kawahara,Tatsuaki Tsuruyama,Hironori Haga, Scientific reports, Vol. 3, p. 2861-2861, 2013/10/04
  • Validation of noninvasive morphological and diffusion imaging in mouse emphysema by micro-computed tomography and hyperpolarized (129)Xe magnetic resonance imaging., Satoshi Tetsumoto,Yoshito Takeda,Hirohiko Imai,Atsuomi Kimura,Yingji Jin,Kaori Nakanishi,Yohei Maeda,Hanako Kuhara,Kazuyuki Tsujino,Takeo Iwasaki,Hiroshi Shigeta,Yasushi Kondo,Mari Ito,Toshiyuki Minami,Haruhiko Hirata,Ryo Takahashi,Satoshi Kohmo,Izumi Nagatomo,Koji Inoue,Hiroshi Kida,Takashi Kijima,Isao Tachibana,Norikazu Maeda,Toru Funahashi,Iichiro Shimomura,Hideaki Fujiwara,Atsushi Kumanogoh, American journal of respiratory cell and molecular biology, Vol. 49, No. 4, p. 592-600, 2013/10
  • Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity., Takayuki Takimoto,Takashi Kijima,Yasushi Otani,Shinpei Nonen,Yoshinobu Namba,Masahide Mori,Soichiro Yokota,Seigo Minami,Kiyoshi Komuta,Junji Uchida,Fumio Imamura,Mitsugi Furukawa,Naotoshi Tsuruta,Yasushi Fujio,Junichi Azuma,Isao Tachibana,Atsushi Kumanogoh, Clinical lung cancer, Vol. 14, No. 5, p. 502-7, 2013/09
  • Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine, T. Maeda,N. Hosen,K. Fukushima,A. Tsuboi,S. Morimoto,T. Matsui,H. Sata,J. Fujita,K. Hasegawa,S. Nishida,J. Nakata,Y. Nakae,S. Takashima,H. Nakajima,F. Fujiki,N. Tatsumi,T. Kondo,M. Hino,Y. Oji,Y. Oka,Y. Kanakura,A. Kumanogoh,H. Sugiyama, Blood Cancer Journal, Vol. 3, No. 8, 2013/08
  • Favorable responses to tocilizumab in two patients with cancer-related cachexia., Haruhiko Hirata,Satoshi Tetsumoto,Takashi Kijima,Hiroshi Kida,Toru Kumagai,Ryo Takahashi,Yasushi Otani,Koji Inoue,Hanako Kuhara,Kazuki Shimada,Izumi Nagatomo,Yoshito Takeda,Sho Goya,Kazuyuki Yoshizaki,Ichiro Kawase,Isao Tachibana,Tadamitsu Kishimoto,Atsushi Kumanogoh, Journal of pain and symptom management, Vol. 46, No. 2, p. e9-e13-e13, 2013/08
  • Echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangement in congenital pulmonary airway malformation., Satoshi Tetsumoto,Takashi Kijima,Eiichi Morii,Sho Goya,Toshiyuki Minami,Haruhiko Hirata,Ryo Takahashi,Satoshi Kohmo,Koji Inoue,Izumi Nagatomo,Yoshito Takeda,Hiroshi Kida,Isao Tachibana,Atsushi Kumanogoh, Clinical lung cancer, Vol. 14, No. 4, p. 457-60, 2013/07
  • Functional human Th17 clones with WT1-specific helper activity., Sho Tachino,Fumihiro Fujiki,Yoshihiro Oka,Akihiro Tsuboi,Soyoko Morimoto,Yu-Hung Lin,Taichi Tamanaka,Kenta Kondo,Hiroko Nakajima,Sumiyuki Nishida,Naoki Hosen,Yusuke Oji,Atsushi Kumanogoh,Haruo Sugiyama, Cancer immunology, immunotherapy : CII, Vol. 62, No. 4, p. 801-10, 2013/04
  • HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T lymphocytes display a helper activity for WT1-specific CTL induction and a cytotoxicity against leukemia cells., Yuhung Lin,Fumihiro Fujiki,Akiko Katsuhara,Yoshihiro Oka,Akihiro Tsuboi,Nao Aoyama,Satoe Tanii,Hiroko Nakajima,Naoya Tatsumi,Soyoko Morimoto,Taichi Tamanaka,Sho Tachino,Naoki Hosen,Sumiyuki Nishida,Yusuke Oji,Atsushi Kumanogoh,Haruo Sugiyama, Journal of immunotherapy (Hagerstown, Md. : 1997), Vol. 36, No. 3, p. 159-70, 2013/04
  • Semaphorins in bone development, homeostasis, and disease., Sujin Kang,Atsushi Kumanogoh, Seminars in cell & developmental biology, Vol. 24, No. 3, p. 163-71, 2013/03
  • Dynamic visualization of RANKL and Th17-mediated osteoclast function., Junichi Kikuta,Yoh Wada,Toshiyuki Kowada,Ze Wang,Ge-Hong Sun-Wada,Issei Nishiyama,Shin Mizukami,Nobuhiko Maiya,Hisataka Yasuda,Atsushi Kumanogoh,Kazuya Kikuchi,Ronald N Germain,Masaru Ishii, The Journal of clinical investigation, Vol. 123, No. 2, p. 866-73, 2013/02
  • [Immune semaphorins and allergic diseases]., Tetsuo Morihana,Atsushi Kumanogoh, Arerugi = [Allergy], Vol. 62, No. 2, p. 155-62, 2013/02
  • Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro., Takeo Iwasaki,Yoshito Takeda,Kazuichi Maruyama,Yasuyuki Yokosaki,Kazuyuki Tsujino,Satoshi Tetsumoto,Hanako Kuhara,Kaori Nakanishi,Yasushi Otani,Yingji Jin,Satoshi Kohmo,Haruhiko Hirata,Ryo Takahashi,Mayumi Suzuki,Koji Inoue,Izumi Nagatomo,Sho Goya,Takashi Kijima,Toru Kumagai,Isao Tachibana,Ichiro Kawase,Atsushi Kumanogoh, The Journal of biological chemistry, Vol. 288, No. 4, p. 2118-31, 2013/01/25
  • Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis, Y. Hishitani,A. Ogata,Y. Shima,T. Hirano,K. Ebina,Y. Kunugiza,K. Shi,M. Narazaki,K. Hagihara,T. Tomita,H. Yoshikawa,T. Tanaka,A. Kumanogoh, SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, INFORMA HEALTHCARE, Vol. 42, No. 4, p. 253-259, 2013
  • An inhibitory role for Sema4A in antigen-specific allergic asthma., Tetsuo Morihana,Sho Goya,Masayuki Mizui,Teruhito Yasui,Durubaka V R Prasad,Atsushi Kumanogoh,Manabu Tamura,Takashi Shikina,Yohei Maeda,Yoriko Iwamoto,Hidenori Inohara,Hitoshi Kikutani, Journal of clinical immunology, Vol. 33, No. 1, p. 200-9, 2013/01
  • Involvement of STAT3 in immune evasion during lung tumorigenesis., Hiroshi Kida,Shoichi Ihara,Atsushi Kumanogoh, Oncoimmunology, Vol. 2, No. 1, 2013/01/01
  • Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin., Yu Nishijima,Haruhiko Hirata,Aiko Himeno,Hiroshi Kida,Masanori Matsumoto,Ryo Takahashi,Yasushi Otani,Kouji Inoue,Izumi Nagatomo,Yoshito Takeda,Takashi Kijima,Isao Tachibana,Yoshihiro Fujimura,Atsushi Kumanogoh, Internal medicine (Tokyo, Japan), Vol. 52, No. 10, p. 1111-4, 2013
  • Calretinin mediates apoptosis in small cell lung cancer cells expressing tetraspanin CD9., Ping He,Hanako Kuhara,Isao Tachibana,Yingji Jin,Yoshito Takeda,Satoshi Tetsumoto,Toshiyuki Minami,Satoshi Kohmo,Haruhiko Hirata,Ryo Takahashi,Koji Inoue,Izumi Nagatomo,Hiroshi Kida,Takashi Kijima,Tetsuji Naka,Eiichi Morii,Ichiro Kawase,Atsushi Kumanogoh, FEBS open bio, Vol. 3, p. 225-30, 2013
  • Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction., Shunsuke Tamaki,Toshiaki Mano,Yasushi Sakata,Tomohito Ohtani,Yasuharu Takeda,Daisuke Kamimura,Yosuke Omori,Yasumasa Tsukamoto,Yukitoshi Ikeya,Mari Kawai,Atsushi Kumanogoh,Keisuke Hagihara,Ryohei Ishii,Mitsuru Higashimori,Makoto Kaneko,Hidetoshi Hasuwa,Takeshi Miwa,Kazuhiro Yamamoto,Issei Komuro, PloS one, Vol. 8, No. 7, 2013
  • Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis., Toshiyuki Minami,Takashi Kijima,Satoshi Kohmo,Hisashi Arase,Yasushi Otani,Izumi Nagatomo,Ryo Takahashi,Kotaro Miyake,Masayoshi Higashiguchi,Osamu Morimura,Shoichi Ihara,Kazuyuki Tsujino,Haruhiko Hirata,Koji Inoue,Yoshito Takeda,Hiroshi Kida,Isao Tachibana,Atsushi Kumanogoh, Scientific reports, Vol. 3, p. 2669-2669, 2013
  • Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages., Yingji Jin,Isao Tachibana,Yoshito Takeda,Ping He,Sujin Kang,Mayumi Suzuki,Hanako Kuhara,Satoshi Tetsumoto,Kazuyuki Tsujino,Toshiyuki Minami,Takeo Iwasaki,Kaori Nakanishi,Satoshi Kohmo,Haruhiko Hirata,Ryo Takahashi,Koji Inoue,Izumi Nagatomo,Hiroshi Kida,Takashi Kijima,Mari Ito,Hideyuki Saya,Atsushi Kumanogoh, PloS one, Vol. 8, No. 9, 2013
  • DNA damage in rheumatoid arthritis: an age-dependent increase in the lipid peroxidation-derived DNA adduct, heptanone-etheno-2'-deoxycytidine., Masako Ogawa,Tomonari Matsuda,Atsushi Ogata,Toshimitsu Hamasaki,Atsushi Kumanogoh,Toshihiko Toyofuku,Toshio Tanaka, Autoimmune diseases, Vol. 2013, p. 183487-183487, 2013
  • Tocilizumab for the treatment of patients with refractory Takayasu arteritis., Yoshikazu Nakaoka,Kaori Higuchi,Yoh Arita,Michio Otsuki,Kaori Yamamoto,Takahiro Hashimoto-Kataoka,Taku Yasui,Kuniyasu Ikeoka,Tomohito Ohtani,Yasushi Sakata,Yoshihito Shima,Atsushi Kumanogoh,Keiko Yamauchi-Takihara,Toshio Tanaka,Tadamitsu Kishimoto,Issei Komuro, International heart journal, Vol. 54, No. 6, p. 405-11, 2013
  • A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degeneration., Satoshi Nojima,Toshihiko Toyofuku,Hiroyuki Kamao,Chie Ishigami,Jun Kaneko,Tatsusada Okuno,Hyota Takamatsu,Daisuke Ito,Sujin Kang,Tetsuya Kimura,Yuji Yoshida,Keiko Morimoto,Yohei Maeda,Atsushi Ogata,Masahito Ikawa,Eiichi Morii,Katsuyuki Aozasa,Junichi Takagi,Masayo Takahashi,Atsushi Kumanogoh, Nature communications, Vol. 4, p. 1406-1406, 2013
  • Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer., Takayuki Shiroyama,Takashi Kijima,Kiyoshi Komuta,Suguru Yamamoto,Seigo Minami,Yoshitaka Ogata,Kouhei Okafuji,Fumio Imamura,Tomonori Hirashima,Isao Tachibana,Ichiro Kawase,Atsushi Kumanogoh, Cancer chemotherapy and pharmacology, Vol. 70, No. 6, p. 783-9, 2012/12
  • Recognition of a natural WT1 epitope by a modified WT1 peptide-specific T-cell receptor., Taichi Tamanaka,Yoshihiro Oka,Fumihiro Fujiki,Akihiro Tsuboi,Akiko Katsuhara,Hiroko Nakajima,Naoki Hosen,Sumiyuki Nishida,Yu-Hung Lin,Sho Tachino,Yoshiki Akatsuka,Kiyotaka Kuzushima,Yusuke Oji,Atsushi Kumanogoh,Haruo Sugiyama, Anticancer research, Vol. 32, No. 12, p. 5201-9, 2012/12
  • Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016., Yasushi Otani,Takashi Kijima,Satoshi Kohmo,Shinya Oishi,Toshiyuki Minami,Izumi Nagatomo,Ryo Takahashi,Haruhiko Hirata,Mayumi Suzuki,Koji Inoue,Yoshito Takeda,Hiroshi Kida,Isao Tachibana,Nobutaka Fujii,Atsushi Kumanogoh, FEBS letters, Vol. 586, No. 20, p. 3639-44, 2012/10/19
  • CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients, N. Hosen,Y. Matsuoka,S. Kishida,J. Nakata,Y. Mizutani,K. Hasegawa,A. Mugitani,H. Ichihara,Y. Aoyama,S. Nishida,A. Tsuboi,F. Fujiki,N. Tatsumi,H. Nakajima,M. Hino,T. Kimura,K. Yata,M. Abe,Y. Oka,Y. Oji,A. Kumanogoh,H. Sugiyama, LEUKEMIA, NATURE PUBLISHING GROUP, Vol. 26, No. 9, p. 2135-2141, 2012/09
  • [Regulation of immune responses by immune semaphorins]., Daisuke Ito,Satoshi Nojima,Atsushi Kumanogoh, Nihon rinsho. Japanese journal of clinical medicine, Vol. 70, No. 9, p. 1633-43, 2012/09
  • The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function., Deborah A Witherden,Megumi Watanabe,Olivia Garijo,Stephanie E Rieder,Gor Sarkisyan,Shane J F Cronin,Petra Verdino,Ian A Wilson,Atsushi Kumanogoh,Hitoshi Kikutani,Luc Teyton,Wolfgang H Fischer,Wendy L Havran, Immunity, Vol. 37, No. 2, p. 314-25, 2012/08/24
  • Dynamism of immune reactions and regulation., Tomohiro Kurosaki,Takashi Saito,Atsushi Kumanogoh,Kiyoshi Takeda,Tsuneyasu Kaisho, International immunology, Vol. 24, No. 8, p. 473-5, 2012/08
  • Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity., Kazuyuki Tsujino,Yoshito Takeda,Toru Arai,Yasushi Shintani,Ryosaku Inagaki,Hiroyuki Saiga,Takeo Iwasaki,Satoshi Tetsumoto,Yingji Jin,Shoichi Ihara,Toshiyuki Minami,Mayumi Suzuki,Izumi Nagatomo,Koji Inoue,Hiroshi Kida,Takashi Kijima,Mari Ito,Masanori Kitaichi,Yoshikazu Inoue,Isao Tachibana,Kiyoshi Takeda,Meinoshin Okumura,Martin E Hemler,Atsushi Kumanogoh, American journal of respiratory and critical care medicine, Vol. 186, No. 2, p. 170-80, 2012/07/15
  • Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis., Shoichi Ihara,Hiroshi Kida,Hisashi Arase,Lokesh P Tripathi,Yi-An Chen,Tetsuya Kimura,Mitsuhiro Yoshida,Yozo Kashiwa,Haruhiko Hirata,Reiko Fukamizu,Ruriko Inoue,Kana Hasegawa,Sho Goya,Ryo Takahashi,Toshiyuki Minami,Kazuyuki Tsujino,Mayumi Suzuki,Satoshi Kohmo,Koji Inoue,Izumi Nagatomo,Yoshito Takeda,Takashi Kijima,Kenji Mizuguchi,Isao Tachibana,Atsushi Kumanogoh, Cancer research, Vol. 72, No. 12, p. 2990-9, 2012/06/15
  • Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing., Takaaki Kuwajima,Yutaka Yoshida,Noriko Takegahara,Timothy J Petros,Atsushi Kumanogoh,Thomas M Jessell,Takeshi Sakurai,Carol Mason, Neuron, Vol. 74, No. 4, p. 676-90, 2012/05/24
  • Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosis., Yuji Nakatsuji,Tatsusada Okuno,Masayuki Moriya,Tomoyuki Sugimoto,Makoto Kinoshita,Hyota Takamatsu,Satoshi Nojima,Tetsuya Kimura,Sujin Kang,Daisuke Ito,Yukinobu Nakagawa,Toshihiko Toyofuku,Kazushiro Takata,Misa Nakano,Masato Kubo,Sinobu Suzuki,Akiko Matsui-Hasumi,Ayako Uto-Konomi,Atsushi Ogata,Hideki Mochizuki,Saburo Sakoda,Atsushi Kumanogoh, Journal of immunology (Baltimore, Md. : 1950), Vol. 188, No. 10, p. 4858-65, 2012/05/15
  • Osteoprotection by semaphorin 3A., Mikihito Hayashi,Tomoki Nakashima,Masahiko Taniguchi,Tatsuhiko Kodama,Atsushi Kumanogoh,Hiroshi Takayanagi, Nature, Vol. 485, No. 7396, p. 69-74, 2012/05/03
  • Endosomal sorting by Semaphorin 4A in retinal pigment epithelium supports photoreceptor survival., Toshihiko Toyofuku,Satoshi Nojima,Takako Ishikawa,Hyota Takamatsu,Tohru Tsujimura,Akiyoshi Uemura,Junko Matsuda,Takaharu Seki,Atsushi Kumanogoh, Genes & development, Vol. 26, No. 8, p. 816-29, 2012/04/15
  • A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab., Toru Hirano,Nobuyuki Ohguro,Satoshi Hohki,Keisuke Hagihara,Yoshihito Shima,Masashi Narazaki,Atsushi Ogata,Kazuyuki Yoshizaki,Atsushi Kumanogoh,Tadamitsu Kishimoto,Toshio Tanaka, Modern rheumatology, Vol. 22, No. 2, p. 298-302, 2012/04
  • HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer., Toshiyuki Minami,Takashi Kijima,Yasushi Otani,Satoshi Kohmo,Ryo Takahashi,Izumi Nagatomo,Haruhiko Hirata,Mayumi Suzuki,Koji Inoue,Yoshito Takeda,Hiroshi Kida,Isao Tachibana,Atsushi Kumanogoh, Molecular cancer therapeutics, Vol. 11, No. 4, p. 830-41, 2012/04
  • Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors., Soyoko Morimoto,Yoshihiro Oka,Akihiro Tsuboi,Yukie Tanaka,Fumihiro Fujiki,Hiroko Nakajima,Naoki Hosen,Sumiyuki Nishida,Jun Nakata,Yoshiki Nakae,Motohiko Maruno,Akira Myoui,Takayuki Enomoto,Shuichi Izumoto,Mitsugu Sekimoto,Naoki Kagawa,Naoya Hashimoto,Toshiki Yoshimine,Yusuke Oji,Atsushi Kumanogoh,Haruo Sugiyama, Cancer Sci., Vol. 103, No. 3, p. 408-414, 2012/03
  • Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors., Soyoko Morimoto,Yoshihiro Oka,Akihiro Tsuboi,Yukie Tanaka,Fumihiro Fujiki,Hiroko Nakajima,Naoki Hosen,Sumiyuki Nishida,Jun Nakata,Yoshiki Nakae,Motohiko Maruno,Akira Myoui,Takayuki Enomoto,Shuichi Izumoto,Mitsugu Sekimoto,Naoki Kagawa,Naoya Hashimoto,Toshiki Yoshimine,Yusuke Oji,Atsushi Kumanogoh,Haruo Sugiyama, Cancer science, Vol. 103, No. 3, p. 408-14, 2012/03
  • Diverse roles for semaphorin-plexin signaling in the immune system., Hyota Takamatsu,Atsushi Kumanogoh, Trends in immunology, Vol. 33, No. 3, p. 127-35, 2012/03
  • Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via αvβ1 integrin., Sujin Kang,Tatsusada Okuno,Noriko Takegahara,Hyota Takamatsu,Satoshi Nojima,Tetsuya Kimura,Yuji Yoshida,Daisuke Ito,Saori Ohmae,Dong-Ju You,Toshihiko Toyofuku,Myoung Ho Jang,Atsushi Kumanogoh, Journal of immunology (Baltimore, Md. : 1950), Vol. 188, No. 3, p. 1108-16, 2012/02/01
  • Therapeutic implications of tocilizumab, a humanized anti-interleukin-6 receptor antibody, for various immune-mediated diseases: An update review, Toshio Tanaka,Atsushi Ogata,Yoshihito Shima,Masashi Narazaki,Atsushi Kumanogoh,Tadamitsu Kishimoto, Current Rheumatology Reviews, Bentham Science Publishers B.V., Vol. 8, No. 3, p. 209-226, 2012
  • Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab., Atsushi Ogata,Noriko Umegaki,Ichiro Katayama,Atsushi Kumanogoh,Toshio Tanaka, Joint bone spine, Vol. 79, No. 1, p. 85-7, 2012/01
  • Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung., Ryo Takahashi,Haruhiko Hirata,Isao Tachibana,Eku Shimosegawa,Atsuo Inoue,Izumi Nagatomo,Yoshito Takeda,Hiroshi Kida,Sho Goya,Takashi Kijima,Mitsuhiro Yoshida,Toru Kumagai,Atsushi Kumanogoh,Meinoshin Okumura,Jun Hatazawa,Ichiro Kawase, Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 18, No. 1, p. 220-8, 2012/01/01
  • Adiponectin: a novel link between adipocytes and COPD., Yoshito Takeda,Kaori Nakanishi,Isao Tachibana,Atsushi Kumanogoh, Vitamins and hormones, Vol. 90, p. 419-35, 2012
  • Pathological role of interleukin-6 in psoriatic arthritis., Atsushi Ogata,Atsushi Kumanogoh,Toshio Tanaka, Arthritis, Vol. 2012, p. 713618-713618, 2012
  • Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for the treatment of autoimmune disorders, Toshio Tanaka,Keisuke Hagihara,Yoshihito Shima,Masashi Narazaki,Atsushi Ogata,Atsushi Kumanogoh, DRUG DEVELOPMENT RESEARCH, WILEY, Vol. 72, No. 8, p. 717-732, 2011/12
  • The role of immune semaphorins in multiple sclerosis., Tatsusada Okuno,Yuji Nakatsuji,Atsushi Kumanogoh, FEBS letters, Vol. 585, No. 23, p. 3829-35, 2011/12/01
  • [Involvement of semaphorins in immune regulations]., Hyota Takamatsu,Atsushi Kumanogoh, Seikagaku. The Journal of Japanese Biochemical Society, Vol. 83, No. 12, p. 1103-9, 2011/12
  • The action of Semaphorin7A on thalamocortical axon branching., Akiko Fukunishi,Takuro Maruyama,Hong Zhao,Manisha Tiwari,Sujin Kang,Atsushi Kumanogoh,Nobuhiko Yamamoto, Journal of neurochemistry, Vol. 118, No. 6, p. 1008-15, 2011/09
  • Ectopic myelinating oligodendrocytes in the dorsal spinal cord as a consequence of altered semaphorin 6D signaling inhibit synapse formation., Jennifer R Leslie,Fumiyasu Imai,Kaori Fukuhara,Noriko Takegahara,Tilat A Rizvi,Roland H Friedel,Fan Wang,Atsushi Kumanogoh,Yutaka Yoshida, Development (Cambridge, England), Vol. 138, No. 18, p. 4085-95, 2011/09
  • [WT1 peptide-based immunotherapy for the treatment of malignancies: focusing on hematological neoplasms]., Yoshihiro Oka,Akihiro Tsuboi,Sumiyuki Nishida,Naoki Hosen,Jun Nakata,Yoshiko Hashii,Tetsuo Maeda,Yusuke Oji,Atsushi Kumanogoh,Haruo Sugiyama, [Rinsho ketsueki] The Japanese journal of clinical hematology, Vol. 52, No. 5, p. 235-42, 2011/05
  • A molecular mechanism that regulates medially oriented axonal growth of upper layer neurons in the developing neocortex., Hong Zhao,Takuro Maruyama,Yuki Hattori,Noriyuki Sugo,Hyota Takamatsu,Atsushi Kumanogoh,Ryuichi Shirasaki,Nobuhiko Yamamoto, The Journal of comparative neurology, Vol. 519, No. 5, p. 834-48, 2011/04/01
  • RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis., Rieko Muramatsu,Takekazu Kubo,Masahiro Mori,Yuka Nakamura,Yuki Fujita,Tsugio Akutsu,Tatsusada Okuno,Junko Taniguchi,Atsushi Kumanogoh,Mari Yoshida,Hideki Mochizuki,Satoshi Kuwabara,Toshihide Yamashita, Nature medicine, Vol. 17, No. 4, p. 488-94, 2011/04
  • Identification of semaphorin 4B as a negative regulator of basophil-mediated immune responses., Yukinobu Nakagawa,Hyota Takamatsu,Tatsusada Okuno,Sujin Kang,Satoshi Nojima,Tetsuya Kimura,Tatsuki R Kataoka,Masahito Ikawa,Toshihiko Toyofuku,Ichiro Katayama,Atsushi Kumanogoh, Journal of immunology (Baltimore, Md. : 1950), Vol. 186, No. 5, p. 2881-8, 2011/03/01
  • Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development., Viola Maier,Christine Jolicoeur,Helen Rayburn,Noriko Takegahara,Atsushi Kumanogoh,Hitoshi Kikutani,Marc Tessier-Lavigne,Wolfgang Wurst,Roland H Friedel, Molecular and cellular neurosciences, Vol. 46, No. 2, p. 419-31, 2011/02
  • Control of bone resorption by semaphorin 4D is dependent on ovarian function., Romain Dacquin,Chantal Domenget,Atsushi Kumanogoh,Hitoshi Kikutani,Pierre Jurdic,Irma Machuca-Gayet, PloS one, Vol. 6, No. 10, 2011
  • The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells., Kazushiro Takata,Makoto Kinoshita,Tatsusada Okuno,Masayuki Moriya,Tohru Kohda,Josephe A Honorat,Tomoyuki Sugimoto,Atsushi Kumanogoh,Hisako Kayama,Kiyoshi Takeda,Saburo Sakoda,Yuji Nakatsuji, PloS one, Vol. 6, No. 11, 2011
  • Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D., Kenneth M Wannemacher,Li Zhu,Hong Jiang,Karen P Fong,Timothy J Stalker,Dooyoung Lee,Anh N Tran,Keith B Neeves,Sean Maloney,Atsushi Kumanogoh,Hitoshi Kikutani,Daniel A Hammer,Scott L Diamond,Lawrence F Brass, Blood, Vol. 116, No. 25, p. 5707-15, 2010/12/16
  • Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements., Noriko Takegahara,Sujin Kang,Satoshi Nojima,Hyota Takamatsu,Tatsusada Okuno,Hitoshi Kikutani,Toshihiko Toyofuku,Atsushi Kumanogoh, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 24, No. 12, p. 4782-92, 2010/12
  • Th1 cells promote neurite outgrowth from cortical neurons via a mechanism dependent on semaphorins., Hiroshi Ishii,Takekazu Kubo,Atsushi Kumanogoh,Toshihide Yamashita, Biochemical and biophysical research communications, Vol. 402, No. 1, p. 168-72, 2010/11/05
  • Structural basis for semaphorin signalling through the plexin receptor., Terukazu Nogi,Norihisa Yasui,Emiko Mihara,Yukiko Matsunaga,Masanori Noda,Naoya Yamashita,Toshihiko Toyofuku,Susumu Uchiyama,Yoshio Goshima,Atsushi Kumanogoh,Junichi Takagi, Nature, Vol. 467, No. 7319, p. 1123-7, 2010/10/28
  • Roles of Sema4D and Plexin-B1 in tumor progression., Ewe Seng Ch'ng,Atsushi Kumanogoh, Molecular cancer, Vol. 9, p. 251-251, 2010/09/21
  • Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice., Kazunori Yukawa,Tetsuji Tanaka,Masanori Kishino,Kenji Yoshida,Noriko Takeuchi,Takuji Ito,Hyota Takamatsu,Hitoshi Kikutani,Atsushi Kumanogoh, International journal of molecular medicine, Vol. 26, No. 1, p. 39-44, 2010/07
  • Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II., Hyota Takamatsu,Noriko Takegahara,Yukinobu Nakagawa,Michio Tomura,Masahiko Taniguchi,Roland H Friedel,Helen Rayburn,Marc Tessier-Lavigne,Yutaka Yoshida,Tatsusada Okuno,Masayuki Mizui,Sujin Kang,Satoshi Nojima,Tohru Tsujimura,Yuji Nakatsuji,Ichiro Katayama,Toshihiko Toyofuku,Hitoshi Kikutani,Atsushi Kumanogoh, Nature immunology, Vol. 11, No. 7, p. 594-600, 2010/07
  • The study of cytokines by Japanese researchers: a historical perspective., Atsushi Kumanogoh,Masato Ogata, International immunology, Vol. 22, No. 5, p. 341-5, 2010/05
  • Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells., Makoto Kinoshita,Yuji Nakatsuji,Takashi Kimura,Masayuki Moriya,Kazushiro Takata,Tatsusada Okuno,Atsushi Kumanogoh,Koji Kajiyama,Hiroo Yoshikawa,Saburo Sakoda, Biochemical and biophysical research communications, Vol. 394, No. 1, p. 205-10, 2010/03/26
  • CD72 negatively regulates KIT-mediated responses in human mast cells., Tatsuki R Kataoka,Atsushi Kumanogoh,Geethani Bandara,Dean D Metcalfe,Alasdair M Gilfillan, Journal of immunology (Baltimore, Md. : 1950), Vol. 184, No. 5, p. 2468-75, 2010/03/01
  • Regulation of immune cell responses by semaphorins and their receptors., Hyota Takamatsu,Tatsusada Okuno,Atsushi Kumanogoh, Cellular & molecular immunology, Vol. 7, No. 2, p. 83-8, 2010/03
  • A midline switch of receptor processing regulates commissural axon guidance in vertebrates., Homaira Nawabi,Anne Briançon-Marjollet,Christopher Clark,Isabelle Sanyas,Hyota Takamatsu,Tatsusada Okuno,Atsushi Kumanogoh,Muriel Bozon,Kaori Takeshima,Yutaka Yoshida,Frédéric Moret,Karima Abouzid,Valérie Castellani, Genes & development, Vol. 24, No. 4, p. 396-410, 2010/02/15
  • Sema4A induces cell morphological changes through B-type plexin-mediated signaling., Kazunori Yukawa,Tetsuji Tanaka,Kenji Yoshida,Noriko Takeuchi,Takuji Ito,Hyota Takamatsu,Hitoshi Kikutani,Atsushi Kumanogoh, International journal of molecular medicine, Vol. 25, No. 2, p. 225-30, 2010/02
  • Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis., Tatsusada Okuno,Yuji Nakatsuji,Masayuki Moriya,Hyota Takamatsu,Satoshi Nojima,Noriko Takegahara,Toshihiko Toyofuku,Yukinobu Nakagawa,Sujin Kang,Roland H Friedel,Saburo Sakoda,Hitoshi Kikutani,Atsushi Kumanogoh, Journal of immunology (Baltimore, Md. : 1950), Vol. 184, No. 3, p. 1499-506, 2010/02/01
  • Semaphorins and their receptors: novel features of neural guidance molecules., Atsushi Kumanogoh,Hitoshi Kikutani, Proceedings of the Japan Academy. Series B, Physical and biological sciences, Vol. 86, No. 6, p. 611-20, 2010
  • Neuromyelitis optica: Passive transfer to rats by human immunoglobulin., Makoto Kinoshita,Yuji Nakatsuji,Takashi Kimura,Masayuki Moriya,Kazushiro Takata,Tatsusada Okuno,Atsushi Kumanogoh,Koji Kajiyama,Hiroo Yoshikawa,Saburo Sakoda, Biochemical and biophysical research communications, Vol. 386, No. 4, p. 623-7, 2009/09/04
  • Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis., Ming Li,Kim M O'Sullivan,Lynelle K Jones,Cecilia Lo,Timothy Semple,Atsushi Kumanogoh,Hitoshi Kikutani,Stephen R Holdsworth,Richard Kitching, Immunology, Vol. 128, No. 1, p. 114-22, 2009/09
  • Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis., Li Zhu,Timothy J Stalker,Karen P Fong,Hong Jiang,Anh Tran,Irene Crichton,Eric K Lee,Keith B Neeves,Sean F Maloney,Hitoshi Kikutani,Atsushi Kumanogoh,Ellen Pure,Scott L Diamond,Lawrence F Brass, Arteriosclerosis, thrombosis, and vascular biology, Vol. 29, No. 7, p. 1039-45, 2009/07
  • [New paradigm on host defence mechanisms]., Atsushi Kumanogoh,Kiyoshi Takeda, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, Vol. 54, No. 8 Suppl, p. 1073-5, 2009/06
  • [Immune semaphorins: involvement of semaphorins in various phases of immune responses]., Noriko Takegahara,Atsushi Kumanogoh, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, Vol. 54, No. 8 Suppl, p. 1101-7, 2009/06
  • Sema4D/CD100 deficiency leads to superior performance in mouse motor behavior., Kazunori Yukawa,Tetsuji Tanaka,Noriko Takeuchi,Hiroyuki Iso,Li Li,Akira Kohsaka,Hidefumi Waki,Masayasu Miyajima,Masanobu Maeda,Hitoshi Kikutani,Atsushi Kumanogoh, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, Vol. 36, No. 3, p. 349-55, 2009/05
  • Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum., Makoto Kinoshita,Yuji Nakatsuji,Masayuki Moriya,Tatsusada Okuno,Atsushi Kumanogoh,Misa Nakano,Toshiyuki Takahashi,Kazuo Fujihara,Keiko Tanaka,Saburo Sakoda, Neuroreport, Vol. 20, No. 5, p. 508-12, 2009/03/25
  • Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12., Masanori Inui,Yuki Kikuchi,Naoko Aoki,Shota Endo,Tsutomu Maeda,Akiko Sugahara-Tobinai,Shion Fujimura,Akira Nakamura,Atsushi Kumanogoh,Marco Colonna,Toshiyuki Takai, Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 12, p. 4816-21, 2009/03/24
  • Sema4D/CD100 DEFICIENCY LEADS TO SUPERIOR PERFORMANCE IN MOUSE MOTOR BEHAVIOR, Kazunori Yukawa,Tetsuji Tanaka,Noriko Takeuchi,Hiroyuki Iso,Li Li,Akira Kohsaka,Hidefumi Waki,Masayasu Miyajima,Masanobu Maeda,Hitoshi Kikutani,Atsushi Kumanogoh, JOURNAL OF PHYSIOLOGICAL SCIENCES, SPRINGER TOKYO, Vol. 59, No. 3, p. 483-483, 2009
  • Immune semaphorins: novel features of neural guidance molecules., Masayuki Mizui,Atsushi Kumanogoh,Hitoshi Kikutani, Journal of clinical immunology, Vol. 29, No. 1, p. 1-11, 2009/01
  • Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development., Quenten Schwarz,Kathryn E Waimey,Matthew Golding,Hyota Takamatsu,Atsushi Kumanogoh,Hajime Fujisawa,Hwai-Jong Cheng,Christiana Ruhrberg, Developmental biology, Vol. 324, No. 1, p. 1-9, 2008/12/01
  • Involvement of Sema4A in the progression of experimental autoimmune myocarditis., Nobuhiko Makino,Toshihiko Toyofuku,Noriko Takegahara,Hyota Takamatsu,Tatsusada Okuno,Yukinobu Nakagawa,Sujin Kang,Satoshi Nojima,Masatsugu Hori,Hitoshi Kikutani,Atsushi Kumanogoh, FEBS letters, Vol. 582, No. 28, p. 3935-40, 2008/11/26
  • Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells., Toshihiko Toyofuku,Junko Yoshida,Tamiko Sugimoto,Midori Yamamoto,Nobuhiko Makino,Hyota Takamatsu,Noriko Takegahara,Fumikazu Suto,Masatsugu Hori,Hajime Fujisawa,Atsushi Kumanogoh,Hitoshi Kikutani, Developmental biology, Vol. 321, No. 1, p. 251-62, 2008/09/01
  • Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis., Masayuki Moriya,Yuji Nakatsuji,Katsuichi Miyamoto,Tatsusada Okuno,Makoto Kinoshita,Atsushi Kumanogoh,Susumu Kusunoki,Saburo Sakoda, Neuroscience letters, Vol. 440, No. 3, p. 323-6, 2008/08/08
  • Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages., Jose Rafael Sierra,Simona Corso,Luisa Caione,Virna Cepero,Paolo Conrotto,Alessandro Cignetti,Wanda Piacibello,Atsushi Kumanogoh,Hitoshi Kikutani,Paolo Maria Comoglio,Luca Tamagnone,Silvia Giordano, The Journal of experimental medicine, Vol. 205, No. 7, p. 1673-85, 2008/07/07
  • Bimodal regulation of T cell-mediated immune responses by TIM-4., Masayuki Mizui,Takashi Shikina,Hisashi Arase,Kazuhiro Suzuki,Teruhito Yasui,Paul D Rennert,Atsushi Kumanogoh,Hitoshi Kikutani, International immunology, Vol. 20, No. 5, p. 695-708, 2008/05
  • Plexin-A4 negatively regulates T lymphocyte responses., Midori Yamamoto,Kazuhiro Suzuki,Tatsusada Okuno,Takehiro Ogata,Noriko Takegahara,Hyota Takamatsu,Masayuki Mizui,Masahiko Taniguchi,Alain Chédotal,Fumikazu Suto,Hajime Fujisawa,Atsushi Kumanogoh,Hitoshi Kikutani, International immunology, Vol. 20, No. 3, p. 413-20, 2008/03
  • Semaphorins and their receptors in immune cell interactions., Kazuhiro Suzuki,Atsushi Kumanogoh,Hitoshi Kikutani, Nature immunology, Vol. 9, No. 1, p. 17-23, 2008/01
  • A novel role for the semaphorin Sema4D in the induction of allo-responses., Raimon Duran-Struuck,Isao Tawara,Kathi Lowler,Shawn G Clouthier,Elizabeth Weisiger,Clare Rogers,Gary Luker,Atsushi Kumanogoh,Chen Liu,James L M Ferrara,Pavan Reddy, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Vol. 13, No. 11, p. 1294-1303, 2007/11
  • CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells., Yoshihiro Kuwano,Charlene M Prazma,Norihito Yazawa,Rei Watanabe,Nobuko Ishiura,Atsushi Kumanogoh,Hitoshi Okochi,Kunihiko Tamaki,Manabu Fujimoto,Thomas F Tedder, International immunology, Vol. 19, No. 8, p. 977-92, 2007/08
  • Tim2 is expressed in mouse fetal hepatocytes and regulates their differentiation., Natsumi Watanabe,Minoru Tanaka,Kaori Suzuki,Atsushi Kumanogoh,Hitoshi Kikutani,Atsushi Miyajima, Hepatology (Baltimore, Md.), Vol. 45, No. 5, p. 1240-9, 2007/05
  • Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin., Kazuhiro Suzuki,Tatsusada Okuno,Midori Yamamoto,R Jeroen Pasterkamp,Noriko Takegahara,Hyota Takamatsu,Tomoe Kitao,Junichi Takagi,Paul D Rennert,Alex L Kolodkin,Atsushi Kumanogoh,Hitoshi Kikutani, Nature, Vol. 446, No. 7136, p. 680-4, 2007/04/05
  • Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1., Toshihiko Toyofuku,Masanori Yabuki,Junko Kamei,Motohiro Kamei,Nobuhiko Makino,Atsushi Kumanogoh,Masatsugu Hori, The EMBO journal, Vol. 26, No. 5, p. 1373-84, 2007/03/07
  • Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury., Li Zhu,Wolfgang Bergmeier,Jie Wu,Hong Jiang,Timothy J Stalker,Marcin Cieslak,Ran Fan,Laurence Boumsell,Atsushi Kumanogoh,Hitoshi Kikutani,Luca Tamagnone,Denisa D Wagner,Marcos E Milla,Lawrence F Brass, Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 5, p. 1621-6, 2007/01/30
  • Immune semaphorins: increasing members and their diverse roles., Hitoshi Kikutani,Kazuhiro Suzuki,Atsushi Kumanogoh, Advances in immunology, Vol. 93, p. 121-43, 2007
  • CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis., Ming Li,Kim M O'Sullivan,Lynelle K Jones,Timothy Semple,Atsushi Kumanogoh,Hitoshi Kikutani,Stephen R Holdsworth,A Richard Kitching, Journal of immunology (Baltimore, Md. : 1950), Vol. 177, No. 5, p. 3406-12, 2006/09/01
  • Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis., Noriko Takegahara,Hyota Takamatsu,Toshihiko Toyofuku,Tohru Tsujimura,Tatsusada Okuno,Kazunori Yukawa,Masayuki Mizui,Midori Yamamoto,Durbaka V R Prasad,Kazuhiro Suzuki,Masaru Ishii,Kenta Terai,Masayuki Moriya,Yuji Nakatsuji,Saburo Sakoda,Shintaro Sato,Shizuo Akira,Kiyoshi Takeda,Masanori Inui,Toshiyuki Takai,Masahito Ikawa,Masaru Okabe,Atsushi Kumanogoh,Hitoshi Kikutani, Nature cell biology, Vol. 8, No. 6, p. 615-22, 2006/06
  • [Semaphorins in immune responses: involvement of Sema4A in T-cell priming and Th1/Th2 regulation]., Kazuhiro Suzuki,Atsushi Kumanogoh, Seikagaku. The Journal of Japanese Biochemical Society, Vol. 78, No. 2, p. 141-5, 2006/02
  • FARP2 triggers signals for Sema3A-mediated axonal repulsion., Toshihiko Toyofuku,Junko Yoshida,Tamiko Sugimoto,Hong Zhang,Atsushi Kumanogoh,Masatsugu Hori,Hitoshi Kikutani, Nature neuroscience, Vol. 8, No. 12, p. 1712-9, 2005/12
  • Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment., Atsushi Kumanogoh,Takashi Shikina,Chie Watanabe,Noriko Takegahara,Kazuhiro Suzuki,Midori Yamamoto,Hyota Takamatsu,Durbaka V R Prasad,Masayuki Mizui,Toshihiko Toyofuku,Manabu Tamura,Dai Watanabe,Jane R Parnes,Hitoshi Kikutani, International immunology, Vol. 17, No. 10, p. 1277-82, 2005/10
  • [Involvement of semaphorins in autoimmunity]., Hyota Takamatsu,Atsushi Kumanogoh, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, Vol. 28, No. 5, p. 327-32, 2005/10
  • Semaphorins: a new class of immunoregulatory molecules., Noriko Takegahara,Atsushi Kumanogoh,Hitoshi Kikutani, Philosophical transactions of the Royal Society of London. Series B, Biological sciences, Vol. 360, No. 1461, p. 1673-80, 2005/09/29
  • Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease., Tatsusada Okuno,Yuji Nakatsuji,Atsushi Kumanogoh,Masayuki Moriya,Hiroshi Ichinose,Hisae Sumi,Harutoshi Fujimura,Hitoshi Kikutani,Saburo Sakoda, Journal of neuroscience research, Vol. 81, No. 6, p. 874-82, 2005/09/15
  • Semaphorin 4A induces growth cone collapse of hippocampal neurons in a Rho/Rho-kinase-dependent manner., Kazunori Yukawa,Tetsuji Tanaka,Tao Bai,Takashi Ueyama,Kyoko Owada-Makabe,Yuji Tsubota,Masanobu Maeda,Kazuhiro Suzuki,Hitoshi Kikutani,Atsushi Kumanogoh, International journal of molecular medicine, Vol. 16, No. 1, p. 115-8, 2005/07
  • [Involvement of semaphorins in immunoregulation]., Masayuki Mizui,Atsushi Kumanogoh, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, Vol. 28, No. 3, p. 109-16, 2005/06
  • Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice., Atsushi Kumanogoh,Takashi Shikina,Kazuhiro Suzuki,Satoshi Uematsu,Kazunori Yukawa,Shin-Ichiro Kashiwamura,Hiroko Tsutsui,Midori Yamamoto,Hyota Takamatsu,Elizabeth P Ko-Mitamura,Noriko Takegahara,Satoko Marukawa,Isao Ishida,Hiroshi Morishita,Durbaka V R Prasad,Manabu Tamura,Masayuki Mizui,Toshihiko Toyofuku,Shizuo Akira,Kiyoshi Takeda,Masaru Okabe,Hitoshi Kikutani, Immunity, Vol. 22, No. 3, p. 305-16, 2005/03
  • Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling., Toshihiko Toyofuku,Hong Zhang,Atsushi Kumanogoh,Noriko Takegahara,Masanori Yabuki,Koichiro Harada,Masatsugu Hori,Hitoshi Kikutani, Nature cell biology, Vol. 6, No. 12, p. 1204-11, 2004/12
  • Woodchuck interleukin-6 gene: structure, characterization, and biologic activity., Daniel H Li,Atsushi Kumanogoh,Thai M Cao,Jane R Parnes,John M Cullen, Gene, Vol. 342, No. 1, p. 157-64, 2004/11/10
  • Induction of cyclooxygenase-2 in reactive glial cells by the CD40 pathway: relevance to amyotrophic lateral sclerosis., Tatsusada Okuno,Yuji Nakatsuji,Atsushi Kumanogoh,Ken Koguchi,Masayuki Moriya,Harutoshi Fujimura,Hitoshi Kikutani,Saburo Sakoda, Journal of neurochemistry, Vol. 91, No. 2, p. 404-12, 2004/10
  • Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2., Toshihiko Toyofuku,Hong Zhang,Atsushi Kumanogoh,Noriko Takegahara,Fumikazu Suto,Junko Kamei,Kazuhiro Aoki,Masanori Yabuki,Masatsugu Hori,Hajime Fujisawa,Hitoshi Kikutani, Genes & development, Vol. 18, No. 4, p. 435-47, 2004/02/15
  • The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion., Caroline Moreau-Fauvarque,Atsushi Kumanogoh,Emeline Camand,Céline Jaillard,Gilles Barbin,Isabelle Boquet,Christopher Love,E Yvonne Jones,Hitoshi Kikutani,Catherine Lubetzki,Isabelle Dusart,Alain Chédotal, The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 23, No. 27, p. 9229-39, 2003/10/08
  • Immune semaphorins: a new area of semaphorin research., Atsushi Kumanogoh,Hitoshi Kikutani, Journal of cell science, Vol. 116, No. Pt 17, p. 3463-70, 2003/09/01
  • Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses., Isao Ishida,Atsushi Kumanogoh,Kazuhiro Suzuki,Shiro Akahani,Kazuhiro Noda,Hitoshi Kikutani, International immunology, Vol. 15, No. 8, p. 1027-34, 2003/08
  • CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses., Kazuhiro Suzuki,Atsushi Kumanogoh,Hitoshi Kikutani, Cytokine & growth factor reviews, Vol. 14, No. 1, p. 17-24, 2003/02
  • Semaphorins in interactions between T cells and antigen-presenting cells., Hitoshi Kikutani,Atsushi Kumanogoh, Nature reviews. Immunology, Vol. 3, No. 2, p. 159-67, 2003/02
  • Roles of the semaphorin family in immune regulation., Atsushi Kumanogoh,Hitoshi Kikutani, Advances in immunology, Vol. 81, p. 173-98, 2003
  • [Involvement of immune semaphorins in the immune system]., Atsushi Kumanogoh, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, Vol. 47, No. 16 Suppl, p. 2254-60, 2002/12
  • Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells., Atsushi Kumanogoh,Kazuhiro Suzuki,EweSeng Ch'ng,Chie Watanabe,Satoko Marukawa,Noriko Takegahara,Isao Ishida,Takehito Sato,Sonoko Habu,Kanji Yoshida,Wei Shi,Hitoshi Kikutani, Journal of immunology (Baltimore, Md. : 1950), Vol. 169, No. 3, p. 1175-81, 2002/08/01
  • Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals., Teruhito Yasui,Masaaki Muraoka,Yuko Takaoka-Shichijo,Isao Ishida,Noriko Takegahara,Junji Uchida,Atsushi Kumanogoh,Sachiko Suematsu,Misao Suzuki,Hitoshi Kikutani, International immunology, Vol. 14, No. 3, p. 319-29, 2002/03
  • Pysiological signaling of CD40 in human CD40-transgenic mice., Yasui T,Hayami K,Kamanaka M,Kumanogoh A,Uchida J,Suematsu S,Suzuki M,Muraguchi A,Kishimoto T,Kikutani H,ed,T. Kishimoto, Leukocyte Typing IV, p. 258-259, 1997

Misc.

  • 抗PD-1抗体結合モニタリングを用いた肺癌治療・有害事象の臨床経過の検討, 内藤 祐二朗,上浪 健,益弘 健太朗,長 彰翁,小山 正平,矢野 幸洋,中坪 彩恵子,赤澤 結貴,金津 正樹,石島 見佳子,白山 敬之,平田 陽彦,長友 泉,武田 吉人,木田 博,森 雅秀,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 59, No. 6, p. 909-909, 2019/11
  • 呼吸器領域におけるレーザー医療の進歩と課題 呼吸器内科領域におけるレーザー医療の適応を肺野末梢へ拡大しうる新技術, 三宅 浩太郎,白山 敬之,佐藤 真吾,仲谷 健史,小山 正平,平田 陽彦,長友 泉,武田 吉人,熊ノ郷 淳, 日本レーザー医学会誌, (NPO)日本レーザー医学会, Vol. 40, No. 3, p. 244-244, 2019/09
  • 胸腺NET切除後の多発肺転移、骨転移、肝転移、膵転移再発に対し、集学的治療を行った1例, 矢賀 元,白井 雄也,光井 雄一,高田 創,益弘 健太朗,白山 敬之,三宅 浩太郎,小山 正平,平田 陽彦,岩堀 幸太,長友 泉,武田 吉人,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 59, No. 4, p. 417-418, 2019/08
  • EGFR遺伝子変異検査において、測定法により異なる結果となった1例, 高田 創,長友 泉,白井 雄也,光井 雄一,益弘 健太朗,矢賀 元,白山 敬之,三宅 浩太郎,小山 正平,岩堀 幸太,平田 陽彦,武田 吉人,木田 博,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 59, No. 4, p. 418-419, 2019/08
  • 進行卵巣癌に対するWT1を標的とした癌ワクチンに関する臨床研究(Clinical Study of the Cancer Vaccine targeting WT1 for Advanced Ovarian Cancer), 西田 純幸,白方 俊章,森本 創世子,榎本 隆之,吉野 潔,冨松 拓治,藤木 文博,尾路 祐介,上田 豊,坪井 昭博,森田 智視,岡 芳弘,熊ノ郷 淳,木村 正,杉山 治夫, 日本がん免疫学会総会プログラム・抄録集, 日本がん免疫学会, Vol. 23回, p. 159-159, 2019/07
  • 進行肺癌に対するCpG ODN(K3)皮下注射による自然免疫の活性化(Activation of innate immunity in patients with advanced lung cancer following subcutaneous injection of CpG ODN(K3)), 大塚 倫之,西田 純幸,濱口 眞成,柴原 理志,白山 敬之,川合 祥子,木村 恵子,平田 陽彦,木田 博,石井 健,熊ノ郷 淳, 日本がん免疫学会総会プログラム・抄録集, 日本がん免疫学会, Vol. 23回, p. 169-169, 2019/07
  • 気道炎症・バイオマーカー 血清エクソソームの最新プロテオミクスによる新規喘息・COPDバイオマーカーの探索, 木庭 太郎,武田 吉人,玄山 宗到,木田 博,植田 幸嗣,野島 陽水,伊藤 眞里,熊ノ郷 淳, アレルギー, (一社)日本アレルギー学会, Vol. 68, No. 4-5, p. 491-491, 2019/05
  • 「新薬創出を加速する人工知能の開発」特発性肺線維症への取り組み, 伊藤眞里,武田吉人,木田博,木庭太郎,野島陽水,藤原大,長尾知生子,夏目やよい,武田理宏,松村泰志,熊ノ郷淳,水口賢司, 日本呼吸器学会誌(Web), Vol. 8, 2019/03/10
  • 間質性肺炎 診断と予後 新薬創出を加速する人工知能の開発 特発性肺線維症への取り組み, 伊藤 眞里,武田 吉人,木田 博,木庭 太郎,野島 陽水,藤原 大,長尾 知生子,夏目 やよい,武田 理宏,松村 泰志,熊ノ郷 淳,水口 賢司, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 8, No. 増刊, p. 167-167, 2019/03
  • 膠原病性間質性肺疾患合併肺高血圧症の診断における%FVC/%DLco比の経年増加の有用性について, 光井 雄一,平田 陽彦,白井 雄也,高田 創,益弘 健太朗,矢賀 元,白山 敬之,三宅 浩太郎,小山 正平,岩堀 幸太,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 8, No. 増刊, p. 307-307, 2019/03
  • 肺病変を認める多中心型キャッスルマン病の後方視的検討, 高田 創,平田 陽彦,白井 雄也,光井 雄一,益弘 健太朗,矢賀 元,白山 敬之,三宅 浩太郎,小山 正平,岩堀 幸太,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 8, No. 増刊, p. 324-324, 2019/03
  • 梅毒に合併する稀な肺病変の2例, 二見 真史,滝本 宜之,平田 陽彦,白山 敬之,三宅 浩太郎,小山 正平,岩堀 幸太,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 8, No. 増刊, p. 330-330, 2019/03
  • TSC-LAMにおける呼吸機能の経時的変化, 矢賀 元,平田 陽彦,白井 雄也,光井 雄一,高田 創,益弘 健太朗,白山 敬之,三宅 浩太郎,小山 正平,岩堀 幸太,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 8, No. 増刊, p. 342-342, 2019/03
  • 骨髄移植後出現した胸部異常陰影に対してBALを実施し,肺胞出血が疑われた7症例の後方視的検討, 益弘 健太朗,平田 陽彦,白井 雄也,光井 雄一,高田 創,矢賀 元,白山 敬之,三宅 浩太郎,小山 正平,岩堀 幸太,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 8, No. 増刊, p. 353-353, 2019/03
  • 新しい多剤耐性肺結核治療DNAワクチンの開発・第1相医師主導治験研究, 岡田 全司,橋元 里実,井上 義一,露口 一成,林 清二,喜多 洋子,齋藤 武文,山根 章,松本 智成,仲谷 均,西松 志保,木岡 由美子,西田 泰子,中島 俊洋,金田 安史,朝野 和典,熊ノ郷 淳,木田 博,庄司 俊輔,三上 礼子,McMurray David,Tan Esterlina,Saunderson Paul,Cang Marjorie, 結核, (一社)日本結核病学会, Vol. 94, No. 3, p. 226-226, 2019/03
  • エクソソームのプロテオミクスによるリンパ脈管筋腫症の血液バイオマーカーの同定, 滝本 宜之,武田 吉人,木庭 太郎,玄山 宗到,木田 博,広瀬 雅樹,井上 義一,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 8, No. 増刊, p. 324-324, 2019/03
  • エクソソームの次世代プロテオミクスが解き明かすサルコイドーシスの新規バイオマーカー, 二見悠,武田吉人,木庭太郎,玄山宗到,玄山宗到,松木隆典,木田博,伊藤眞里,水口賢,植田幸嗣,熊ノ郷淳, 日本サルコイドーシス/肉芽腫性疾患学会雑誌, 日本サルコイドーシス, Vol. 38, No. サプリメント号, p. 65-65, 2018/10/05
  • 間質性肺炎合併肺癌でPET-CT陽性N2リンパ節にEBUS-TBNAによる診断が重要であった1例, 菅 泰彦,平田 陽彦,内藤 祐二朗,木庭 太郎,三宅 浩太郎,小山 正平,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 58, No. 5, p. 367-367, 2018/10
  • ROS1融合遺伝子陽性肺癌にペメトレキセドを含む化学療法で長期病勢制御を認めた1例, 佐藤 真吾,二見 真史,濱口 眞成,玄山 宗到,三宅 浩太郎,小山 正平,岩堀 幸太,平田 陽彦,滝本 宜之,長友 泉,武田 吉人,木田 博,熊ノ郷 淳,星野 茂則, 肺癌, (NPO)日本肺癌学会, Vol. 58, No. 5, p. 372-372, 2018/10
  • TPS高値症例におけるペムブロリズマブ奏効例と非奏効例の末梢血免疫プロファイル解析, 内藤 祐二朗,長 彰翁,小山 正平,白山 敬之,三宅 浩太郎,岩堀 幸太,平田 陽彦,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 58, No. 6, p. 649-649, 2018/10
  • 新しい多剤耐性結核治療DNAワクチンの開発・第1相医師主導治験に向けた研究, 岡田 全司,橋元 里実,井上 義一,露口 一成,林 清二,喜多 洋子,仲谷 均,西松 志保,木岡 由美子,西田 泰子,中島 俊洋,金田 安史,朝野 和典,熊ノ郷 淳,木田 博,庄司 俊輔,山根 章,齋藤 武文,松本 智成,三上 礼子,McMurray David,Tan Esterlina,Saunderson Paul,Cang Marjorie, 結核, (一社)日本結核病学会, Vol. 93, No. 4, p. 291-291, 2018/04
  • 関節リウマチ合併のアミロイドーシスの予後,ANSWERコホート, 平野亨,原良太,吉田周造,永井孝治,孫瑛洙,安室秀樹,村田浩一,山本渉,山本渉,明石健吾,大西輝,片山昌紀,蛯名耕介,橋本求,熊ノ郷淳, 日本リウマチ学会総会・学術集会プログラム・抄録集, Vol. 62nd, 2018/03/20
  • Semaphorin7AはEGFR‐TKIの治療抵抗性の新規メカニズムに関与する, 甲原雄平,長友泉,小山正平,木島貴志,木田博,熊ノ郷淳, 日本呼吸器学会誌(Web), Vol. 7, 2018/03/10
  • シェーグレン症候群に伴う膠原病肺に肺移植を施行した1例, 木庭太郎,平田陽彦,玄山宗到,三宅浩太郎,小山正平,岩堀幸太,滝本宜之,長友泉,武田吉人,木田博,熊ノ郷淳, 日本呼吸器学会誌(Web), Vol. 7, 2018/03/10
  • 肺リンパ脈管筋腫症におけるエクソソームの最新プロテオーム解析, 滝本 宜之,武田 吉人,木庭 太郎,玄山 宗到,木田 博,広瀬 雅樹,井上 義一,鳴海 良平,朝長 毅,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 7, No. 増刊, p. 128-128, 2018/03
  • シェーグレン症候群に伴う膠原病肺に肺移植を施行した1例, 木庭 太郎,平田 陽彦,玄山 宗到,三宅 浩太郎,小山 正平,岩堀 幸太,滝本 宜之,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 7, No. 増刊, p. 94-94, 2018/03
  • 肺リンパ脈管筋腫症におけるエクソソームの最新プロテオーム解析, 滝本 宜之,武田 吉人,木庭 太郎,玄山 宗到,木田 博,広瀬 雅樹,井上 義一,鳴海 良平,朝長 毅,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 7, No. 増刊, p. 128-128, 2018/03
  • RBM7によるnon-coding RNA分解を介した臓器線維化制御, 福島 清春,佐藤 荘,木田 博,熊ノ郷 淳,審良 静男, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 7, No. 増刊, p. 146-146, 2018/03
  • Semaphorin7AはEGFR-TKIの治療抵抗性の新規メカニズムに関与する, 甲原 雄平,長友 泉,小山 正平,木島 貴志,木田 博,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 7, No. 増刊, p. 174-174, 2018/03
  • エクソソームの最新プロテオミクスによる喘息・COPDの新規バイオマーカー探索, 玄山 宗到,武田 吉人,木庭 太郎,葉山 善友,滝本 宜之,木田 博,植田 幸嗣,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 7, No. 増刊, p. 213-213, 2018/03
  • 血清エクソソームのプロテオミクスを用いた線維化バイオマーカーの探索, 松木 隆典,武田 吉人,木庭 太郎,玄山 宗到,滝本 宜之,木田 博,熊ノ郷 淳,伊藤 眞里,植田 幸嗣, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 7, No. 増刊, p. 231-231, 2018/03
  • 肺線維症進展に関わる新規分子標的の同定, 福島 清春,佐藤 荘,木田 博,熊ノ郷 淳,審良 静男, 日本内科学会雑誌, (一社)日本内科学会, Vol. 107, No. Suppl., p. 217-217, 2018/02
  • 放射線照射歴のある肺癌患者に発症した上大静脈症候群に対して血管内ステント留置術を行い、ステント内血栓症と菌血症を発症した1例, 濱口 眞成,木庭 太郎,玄山 宗到,小山 正平,平田 陽彦,岩堀 幸太,滝本 宜之,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 57, No. 7, p. 882-882, 2017/12
  • CARBOPLATIN PLUS WEEKLY NANOPARTICLE ALBUMIN-BOUND PACLITAXEL IN ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED SQUAMOUS NON-SMALL-CELL LUNG CANCER SELECTED BASED ON MINI NUTRITIONAL ASSESSMENT SHORT-FORM SCORES, Takayuki Shiroyama,Motohiro Tamiya,Seigo Minami,Takeshi Uenami,Masahide Mori,Hidekazu Suzuki,Norio Okamoto,Kiyoshi Komuta,Tomonori Hirashima,Atsushi Kumanogoh,Takashi Kijima, RESPIROLOGY, WILEY, Vol. 22, p. 115-115, 2017/11
  • mTOR signaling plays a crucial role in IFN-beta non-responsiveness in MS patients with high serum Sema4A levels, A. H. Namba,T. Okuno,T. Koda,K. Yamashita,M. Shimizu,M. Kinoshita,A. Kumanogoh,Y. Miyazaki,M. Niino,K. Miyamoto,Y. Nakatsuji,H. Mochizuki, MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Vol. 23, p. 845-846, 2017/10
  • 肺腺癌のセマフォリン7AはmTORシグナルによって制御され、EGFR-TKIの治療耐性に関わっている, 甲原 雄平,長友 泉,岩堀 幸太,木島 貴志,熊ノ郷 淳, 日本癌学会総会記事, 日本癌学会, Vol. 76回, p. P-3266, 2017/09
  • 「検査側を上にした側臥位」での気管支鏡検査の有用性, 三宅 浩太郎,玄山 宗到,濱口 眞成,佐藤 真吾,二見 真史,平田 陽彦,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 気管支学, (NPO)日本呼吸器内視鏡学会, Vol. 39, No. 5, p. 468-468, 2017/09
  • ニボルマブの薬剤性肺障害に対するステロイド加療中に発症し、肺障害再燃との鑑別を要した肺MAC症の1例, 木庭 太郎,平田 陽彦,長友 泉,内藤 祐二朗,濱口 眞成,玄山 宗到,大塚 倫之,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 結核, (一社)日本結核病学会, Vol. 92, No. 6, p. 473-473, 2017/06
  • コバスv2法でT790M陰性腫瘤がオシメルチニブにより縮小した肺腺癌の1例, 木庭 太郎,平田 陽彦,内藤 祐二朗,濱口 眞成,大塚 倫之,玄山 宗到,長友 泉,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 57, No. 3, p. 242-242, 2017/06
  • 早期に評価できたオシメルチニブの脳転移奏効2症例, 岡森 仁臣,木庭 太郎,平田 陽彦,内藤 祐二朗,濱口 眞成,大塚 倫之,玄山 宗到,長友 泉,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 57, No. 3, p. 242-243, 2017/06
  • 切除不能進行膵癌に対するゲムシタビン併用HLA拘束性WT1ペプチドワクチン療法で誘導されたWT1特異的CTLの免疫学的機能解析, 森本 創世子,西田 純幸,小井戸 薫雄,江川 新一,石川 剛,石井 淳,菅野 良秀,柳本 泰明,江口 英利,中田 潤,保仙 直毅,坪井 昭博,長谷川 加奈,中島 博子,藤木 文博,尾路 祐介,熊ノ郷 淳,岡 芳弘,杉山 治夫, 日本がん免疫学会総会プログラム・抄録集, 日本がん免疫学会, Vol. 21回, p. 104-104, 2017/06
  • 当院におけるリンパ脈管筋腫症(LAM)に対する薬物治療の検討, 滝本 宜之,平田 陽彦,木庭 太郎,大塚 倫之,長友 泉,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 気管支学, (NPO)日本呼吸器内視鏡学会, Vol. 39, No. Suppl., p. S421-S421, 2017/05
  • びまん性肺疾患 バイオマーカー 最新プロテオミクスによる肺リンパ脈管筋腫症の新規バイオマーカーの探索, 滝本 宜之,武田 吉人,白水 崇,平田 陽彦,玄山 宗到,木田 博,木島 貴志,朝長 毅,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 6, No. 増刊, p. 138-138, 2017/03
  • 肺腺癌におけるSemaphorin7Aの機能解析, 甲原 雄平,長友 泉,小山 正平,菅 泰彦,長 彰翁,東口 将佳,大塚 倫之,玄山 宗到,平田 陽彦,岩堀 幸太,滝本 宜之,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 6, No. 増刊, p. 203-203, 2017/03
  • TCGAデータベースにて発見したCHK2 K373Eの生物学的意義の検討, 東口 将佳,長友 泉,木島 貴志,菅 泰彦,森村 治,三宅 浩太郎,南 俊行,小山 正平,平田 陽彦,岩堀 幸太,滝本 宜之,武田 吉人,木田 博,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 6, No. 増刊, p. 203-203, 2017/03
  • 特発性肺線維症(IPF)の新たなバイオマーカー 血清抗myxovirus resistance protein-1(MX1)自己抗体, 新井 徹,木田 博,濱野 芳匡,広瀬 雅樹,村上 昭弘,香川 智子,松室 昭子,杉本 親寿,審良 正則,北市 正則,井原 祥一,熊ノ郷 淳,井上 義一, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 6, No. 増刊, p. 215-215, 2017/03
  • 難治性または耐性結核の治療 新しい結核ワクチンの役割と開発の現状, 岡田 全司,橋元 里実,仲谷 均,西松 志保,木岡 由美子,西田 泰子,井上 義一,露口 一成,林 清二,喜多 洋子,中島 俊洋,金田 安史,朝野 和典,熊ノ郷 淳,木田 博,庄司 俊輔,齋藤 武文,松本 智成,三上 礼子,McMurray David,Tan Esterlina,Saunderson Paul,Cang Marjorie, 結核, (一社)日本結核病学会, Vol. 92, No. 2, p. 162-162, 2017/02
  • The Diagnostic Utility Of Chest CT Scan And Bronchoscopy For Pulmonary Mucormycosis In Patients With Hematological Malignancy: A Report Of Two Cases, Y. Naito,H. Hirata,M. Kuroyama,T. Koba,M. Hamaguchi,T. Otsuka,I. Nagatomo,Y. Takeda,H. Kida,T. Kijima,A. Kumanogoh, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, Vol. 195, 2017
  • Trastuzumab Emtansine (T-DM1) Suppresses the Growth of HER2-Positive Small-Cell Lung Cancer in Preclinical Models, Osamu Morimura,Toshiyuki Minami,Takashi Kijima,Shohei Koyama,Tomoyuki Otsuka,Yuhei Kinehara,Akio Osa,Masayoshi Higashiguchi,Kotaro Miyake,Izumi Nagatomo,Haruhiko Hirata,Kota Iwahori,Takayuki Takimoto,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, Vol. 12, No. 1, p. S716-S717, 2017/01
  • 当院におけるニボルマブ使用経験, 長 彰翁,小山 正平,二見 悠,菅 泰彦,内藤 祐二郎,石島 見佳子,木庭 太郎,濱口 眞成,玄山 宗到,大塚 倫之,平田 陽彦,岩堀 幸太,滝本 宜之,長友 泉,武田 吉人,木田 博,熊ノ郷 淳,木島 貴志, 肺癌, (NPO)日本肺癌学会, Vol. 56, No. 7, p. 1067-1067, 2016/12
  • ANTI-GM-CSF/HLA CLASS II COMPLEX AUTOANTIBODY IN AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS, H. Kida,Y. Hamano,M. Hirose,A. Matsumuro,T. Suenaga,H. Sarashina,Y. Inoue,A. Hisashi,A. Kumanogoh, RESPIROLOGY, WILEY-BLACKWELL, Vol. 21, p. 52-52, 2016/11
  • EGFR遺伝子変異陽性非小細胞肺癌で細胞障害性Tリンパ球浸潤が減少する分子学的機序, 竹内 美子,冨樫 庸介,杉山 栄里,木島 貴志,熊ノ郷 淳,新谷 康,奥村 明之進,青景 圭樹,菱田 智之,石井 源一郎,坪井 正博,西川 博嘉, 肺癌, (NPO)日本肺癌学会, Vol. 56, No. 6, p. 529-529, 2016/11
  • 当院におけるニボルマブの使用経験, 長 彰翁,小山 正平,内藤 祐二郎,木庭 太郎,濱口 眞成,玄山 宗到,大塚 倫之,平田 陽彦,岩堀 幸太,滝本 宜之,長友 泉,武田 吉人,木田 博,熊ノ郷 淳,木島 貴志, 肺癌, (NPO)日本肺癌学会, Vol. 56, No. 6, p. 713-713, 2016/11
  • The Analysis of Severity of Arthritis in the Intestinal Microbiota-Humanized Mice, Yuichi Maeda,Masato Matsushita,Masashi Narazaki,Yukihiko Saeki,Atsushi Kumanogoh,Kiyoshi Takeda, ARTHRITIS & RHEUMATOLOGY, WILEY, Vol. 68, 2016/10
  • 免疫療法との併用の可能性についてのEGFR-TKIとdocetaxelの比較検討, 岩堀 幸太,金沢 崇之,後藤 久充子,松本 光史,森本 晶子,河嶋 厚成,木島 貴志,熊ノ郷 淳,和田 尚, 日本癌学会総会記事, 日本癌学会, Vol. 75回, p. P-3218, 2016/10
  • CD43分子上の糖鎖修飾が白血病に腫瘍抗原特異的CTLに対する抵抗性をもたらす, 長谷川 加奈,中島 博子,西田 純幸,坪井 昭博,岡 芳弘,尾路 祐介,熊ノ郷 淳,杉山 治夫,保仙 直毅, 日本癌学会総会記事, 日本癌学会, Vol. 75回, p. J-3065, 2016/10
  • mTOR Complex Signaling through the SEMA4A Plexin 62 Axis Is Required for Optimal Activation and Differentiation of CD8+T Cells, Daisuke Ito,Atsushi Kumanogoh, JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 196, 2016/05
  • 肺腺癌と肺扁平上皮癌の重複癌に対してアファチニブにて治療を行い奏功した1例, 高田 真実,大塚 倫之,菅 泰彦,西嶌 悠,石島 見佳子,玄山 宗到,岩堀 幸太,平田 陽彦,小山 正平,滝本 宜之,長友 泉,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 56, No. 2, p. 144-144, 2016/04
  • がん免疫療法 再発ハイリスク同種造血幹細胞移植後患者に対するWT1ペプチドワクチン臨床試験, 保仙 直毅,前田 哲生,森本 創世子,高島 聡士,中田 潤,西田 純幸,坪井 昭博,尾路 祐介,岡 芳弘,熊ノ郷 淳,杉山 治夫, MHC: Major Histocompatibility Complex, 日本組織適合性学会, Vol. 23, No. 1, p. 71-71, 2016/04
  • 自己免疫性肺胞蛋白症における抗GM-CSF/HLA class II複合体抗体の意義, 濱野 芳匡,木田 博,末永 忠広,井上 義一,荒瀬 尚,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 5, No. 増刊, p. 138-138, 2016/03
  • SEMA4A Contributes Eosinopillic Phenotypes in Asthma and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Yohei Maeda,Masaki Hayama,Kazuya Takeda,Atsushi Kumanogoh,Hidenori Inohara, JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY-ELSEVIER, Vol. 137, No. 2, p. AB263-AB263, 2016/02
  • Autoantibody Against Gm-Csf Presented By Mhc Class Ii In Autoimmune Pulmonary Alveolar ProteINOSis, Y. Hamano,H. Kida,M. Hirose,A. Matsumuro,T. Suenaga,H. Sarashina,T. Hamasaki,Y. Inoue,H. Arase,A. Kumanogoh, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, Vol. 193, 2016
  • Serum Anti-Myxovirus Resistance Protein-1 Autoantibody; A Possible Novel Biomarker For Disease Severity And Prognosis Of Idiopathic Pulmonary Fibrosis, T. Arai,H. Kida,Y. Hamano,M. Hirose,A. Murakami,T. Kagawa,A. Matsumuro,T. Koba,C. Sugimoto,M. Akira,M. Kitaichi,S. Ihara,A. Kumanogoh,Y. Inoue, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, Vol. 193, 2016
  • 慢性特発性間質性肺炎の新たなentityを形成する抗Mx1自己抗体の意義, 濱野 芳匡,木田 博,井原 祥一,Tripthi Lokesh,広瀬 雅樹,西川 博嘉,本多 修,水口 賢司,富山 憲幸,井上 義一,熊ノ郷 淳, 日本臨床免疫学会会誌, 日本臨床免疫学会, Vol. 38, No. 4, p. 327-327, 2015/09
  • サーファクタントプロテインD(SP-D)の消化管における新しい機能の解明, 貴田 葉菜,更級,姜 秀辰,木田 博,須田 亙,服部 正平,熊ノ郷 淳,根岸 英雄,谷口 維紹, 日本臨床免疫学会会誌, 日本臨床免疫学会, Vol. 38, No. 4, p. 345-345, 2015/09
  • Erlotinib少量投与にて病勢がコントロールできた肺腺癌の1例, 甲原 雄平,木島 貴志,葉山 善友,福島 清春,竹内 美子,南 俊行,平田 陽彦,井上 幸治,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 55, No. 4, p. 306-306, 2015/08
  • EGFR-TKI投与中に急性膵炎を発症した2例, 石島 見佳子,大塚 倫之,菅 泰彦,西嶌 悠,玄山 宗到,平田 陽彦,南 俊行,井上 幸治,長友 泉,武田 吉人,木田 博,熊ノ郷 淳,木島 貴志, 肺癌, (NPO)日本肺癌学会, Vol. 55, No. 4, p. 312-312, 2015/08
  • アファチニブ投与後にStevens-Johnson症候群(SJS)を発症した肺腺癌の1例, 野田 成美,大塚 倫之,松木 隆典,石島 見佳子,長 彰翁,仲谷 健史,南 俊行,岩堀 幸太,平田 陽彦,井上 幸治,長友 泉,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 55, No. 4, p. 312-312, 2015/08
  • ALK陽性肺癌に対して、クリゾチニブ投与後にアレクチニブを投与した2例, 葛谷 憲太郎,岩堀 幸太,平田 陽彦,仲谷 健史,長 彰翁,石島 見佳子,松木 隆典,南 俊行,長友 泉,井上 幸治,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 55, No. 1, p. 72-72, 2015/02
  • Preface, Atsushi Kumanogoh, Semaphorins: A Diversity of Emerging Physiological and Pathological Activities, Springer Japan, p. V-VI, 2015/01/01
  • Semaphorins a diversity of emerging physiological and pathological activities, Atsushi Kumanogoh, Semaphorins: A Diversity of Emerging Physiological and Pathological Activities, Springer Japan, p. 1-226, 2015/01/01
  • Validation of Vesmeter As a Diagnostic Tool of Scleroderma., Yoshihiro Hishitani,Yoshihito Shima,Toshio Tanaka,Atsushi Kumanogoh, ARTHRITIS & RHEUMATOLOGY, WILEY-BLACKWELL, Vol. 66, p. S747-S747, 2014/10
  • Involvement of Sema4A in multiple sclerosis and neuromyelitis optica, Tatsusada Okuno,Toru Koda,Katsuichi Miyamoto,Kazushiro Takata,Josephe A. Honorat,Susumu Kusunoki,Atsushi Kumanogoh,Yuji Nakatsuji,Hideki Mochizuki, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 275, No. 1-2, p. 43-43, 2014/10
  • Targeting stepwise HER2 and VEGF can overcome multidrug resistance in small cell lung cancer, Toshiyuki Minami,Takashi Kijima,Osamu Morimura,Yuhei Kinehara,Masayoshi Higashiguchi,Kotaro Miyake,Haruhiko Hirata,Yoshiko Takeuchi,Kiyoharu Fukushima,Yoshitomo Hayama,Koji Inoue,Izumi Nagatomo,Yoshito Takeda,Hiroshi Kida,Atsushi Kumanogoh, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 74, No. 19, 2014/10
  • Investigation of Sema4A as a biomarker for treatment selection for multiple sclerosis, Toru Koda,Tatsusada Okuno,Yuji Nakatsujj,Kazushiro Takata,Josephe Archie Honorat,Akiko Namba,Saburo Sakoda,Atsushi Kumanogoh,Hideki Mochizuki, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 275, No. 1-2, p. 20-21, 2014/10
  • HER2陽性再発小細胞肺癌に対するtrastuzumab+irinotecan併用療法 基礎研究から臨床応用まで, 南 俊行,甲原 雄平,木島 貴志,森村 治,三宅 浩太郎,大塚 倫之,竹内 美子,井上 幸治,長友 泉,木田 博,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 54, No. 5, p. 381-381, 2014/10
  • 当院における胸部悪性腫瘍に対するWT1ペプチド免疫療法, 大塚 倫之,武田 吉人,保仙 直毅,岡 芳弘,南 俊行,平田 陽彦,井上 幸治,長友 泉,木田 博,坪井 昭博,尾路 祐介,木島 貴志,杉山 治夫,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 54, No. 5, p. 562-562, 2014/10
  • EphA2レセプター阻害はセネッセンス誘導を介して小細胞肺がん細胞の増殖を抑制する(EphA2 receptor inhibition suppresses proliferation of small cell lung cancer (SCLC) cells via cell senescenece), 森村 治,南 俊行,木島 貴志,武田 吉人,長友 泉,熊ノ郷 淳, 日本癌学会総会記事, 日本癌学会, Vol. 73回, p. J-1070, 2014/09
  • 胸部CTを手動解析するスイッチオブリーク法と仮想気管支鏡ナビゲーションシステムによる自動解析の相違, 三宅 浩太郎,木島 貴志,仲谷 健史,長 彰翁,石島 見佳子,松木 隆典,竹内 美子,葉山 善友,甲原 雄平,福島 清春,東口 将佳,森村 治,大塚 倫之,南 俊行,平田 陽彦,長友 泉,井上 幸治,武田 吉人,木田 博,熊ノ郷 淳, 気管支学, (NPO)日本呼吸器内視鏡学会, Vol. 36, No. 5, p. 569-569, 2014/09
  • 癌性胸膜炎に対しタルクによる胸膜癒着術を行った症例の検討, 野田 成美,大塚 倫之,石島 見佳子,長 彰翁,仲谷 健史,松木 隆典,南 俊行,平田 陽彦,長友 泉,武田 吉人,木田 博,熊ノ郷 淳,木島 貴志, 肺癌, (NPO)日本肺癌学会, Vol. 54, No. 4, p. 237-237, 2014/08
  • クリゾチニブ投与時に予防的制吐剤投与を行ったALK融合遺伝子陽性肺癌の2例, 石島 見佳子,竹内 美子,松木 隆典,長 彰翁,仲谷 健史,大塚 倫之,平田 陽彦,南 俊行,井上 幸治,長友 泉,武田 吉人,木田 博,熊ノ郷 淳,木島 貴志, 肺癌, (NPO)日本肺癌学会, Vol. 54, No. 4, p. 239-239, 2014/08
  • INCREASED SOLUBLE SEMAPHORIN 4D IN RHEUMATOID ARTHRITIS, Y. Yoshida,A. Ogata,T. Tomita,S. Kang,T. Hirano,Y. Shima,M. Narazaki,T. Tanaka,A. Kumanogoh, ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, Vol. 73, p. 854-855, 2014/06
  • ベバシズマブ併用導入化学療法が奏効し、継続維持療法に移行できた肺大細胞神経内分泌癌の1例, 時政 雄平,木島 貴志,葉山 善友,福島 清春,竹内 美子,東口 将佳,三宅 浩太郎,森村 治,南 俊行,平田 陽彦,井上 幸治,長友 泉,武田 吉人,木田 博,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 54, No. 2, p. 96-96, 2014/04
  • 網羅的自己抗体検索によるINSIP特異的マーカー、抗Mx1抗体の同定, 木田 博,濱野 芳匡,井原 祥一,井上 義一,新井 徹,広瀬 雅樹,矢野 幸洋,森 雅秀,南 俊行,平田 陽彦,長友 泉,井上 幸治,武田 吉人,木島 貴志,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 3, No. 増刊, p. 319-319, 2014/03
  • 特発性非特異的間質性肺炎診断における抗Mx1抗体の有用性, 濱野 芳匡,木田 博,森島 淳仁,平野 亨,楢崎 雅司,嶋 良仁,緒方 篤,立花 功,田中 敏郎,熊ノ郷 淳, 日本リウマチ学会総会・学術集会プログラム・抄録集, (一社)日本リウマチ学会, Vol. 58回, p. 667-667, 2014/03
  • Tetraspanins Cd9 And Cd81 Double-Knockout Mice Spontaneously Develop Not Only COPD-Like Phenotype, But Also Multiple Aging Phenotypes, Y. Takeda,Y. Jin,T. Kijima,I. Tachibana,A. Kumanogoh, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, Vol. 189, 2014
  • Identification Of Anti-Myxovirus Resistance Protein-1 Autoantibody As A Specific Marker For Idiopathic Nonspecific Interstitial Pneumonia, Y. Hamano,H. Kida,S. Ihara,H. Nishikawa,T. Arai,M. Hirose,L. P. Tripathi,T. Kimura,Y. Tada,Y. Yano,M. Mori,K. Mizuguchi,S. Sakaguchi,Y. Inoue,A. Kumanogoh, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, Vol. 189, 2014
  • 難知性希少肺疾患(肺胞蛋白症,先天性間質性肺疾患,オスラー病)に関する調査研究 蛋白アレイ法を用いた自己免疫性肺胞蛋白症の自己抗体解析に関する研究, 木田博,井上義一,濱野芳匡,水口賢司,TRIPATHI Lokesh P,広瀬雅樹,多田康子,西川博嘉,熊ノ郷淳, 難治性稀少肺疾患(肺胞蛋白症、先天性間質性肺疾患、オスラー病)に関する調査研究 平成25年度 総括・分担研究報告書, p. 143-145, 2014
  • Roles of Sema4A in multiple sclerosis and interferon-β therapy efficacy, Yuji Nakatsuji,Tatsusada Okuno,Toru Koda,Kazushiro Takata,Josephe A. Honorat,Hideki Mochizuki,Atsushi Kumanogoh, Clinical and Experimental Neuroimmunology, Vol. 4, No. 3, p. 274-282, 2013/12
  • Prognostic Factors Of Visual Function In The Treatment With Infliximab For Uveitis Of Behcet's Disease, Akihiko Nakabayashi,Toru Hirano,Yoshihiro Hishitani,Keisuke Hagihara,Kei Nakai,Kouji Nishida,Atsushi Kumanogoh, ARTHRITIS AND RHEUMATISM, WILEY-BLACKWELL, Vol. 65, p. S1119-S1120, 2013/10
  • Sema4A enhances Th cell adhesion and neuroinflammation; implications for multiple sclerosis pathogensis, T. Okuno,T. Koda,J. Honorat,K. Takata,H. Mochizuki,A. Kumanogoh,Y. Nakatsuji, MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Vol. 19, No. 11, p. 140-141, 2013/10
  • The efficacy of interferon beta in experimental autoimmune encephalomyelitis (EAE) is inhibited by Sema4A: implications for interferon beta resistance in multiple sclerosis, T. Koda,T. Okuno,J. Honorat,K. Takata,S. Tada,M. Kinoshita,S. Sakoda,A. Kumanogoh,H. Mochizuki,Y. Nakatsuji, MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Vol. 19, No. 11, p. 377-377, 2013/10
  • Double deletion of tetraspanins CD9 and CD81 in mice develops COPD-like phenotype with a syndrome resembling aging, Yoshito Takeda,Yingji Jin,Yasushi Kondo,Mari Ito,Isao Tachibana,Atsushi Kumanogoh, EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, Vol. 42, 2013/09
  • 精密なCT読影法で広がる、極細径気管支鏡の可能性, 三宅 浩太郎,竹内 美子,葉山 善友,時政 雄平,福島 清春,東口 将佳,森村 治,南 俊行,平田 陽彦,長友 泉,井上 幸治,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 気管支学, (NPO)日本呼吸器内視鏡学会, Vol. 35, No. 5, p. 572-573, 2013/09
  • HLA-DPB1*05:01拘束性WT1特異的TCRを導入されたCD4+T細胞はヘルパー活性と細胞傷害活性を有する, 藤木 文博,林 兪宏,勝原 晶子,岡 芳弘,坪井 昭博,青山 奈央,谷井 里江,中島 博子,森本 創世子,保仙 直毅,西田 純幸,尾路 祐介,熊ノ郷 淳,杉山 治夫, 日本がん免疫学会総会プログラム・抄録集, 日本がん免疫学会, Vol. 17回, p. 85-85, 2013/07
  • SEMAPHORIN3A AND SEMAPHORIN4D IN RHEUMATOID ARTHRITIS, Y. Yoshida,S. Kang,A. Morishima,N. Akihiko,Y. Hishitani,Y. Maeda,M. Nishide,M. Hamano,K. Morimoto,T. Hirano,Y. Shima,M. Narazaki,T. Tanaka,A. Ogata,A. Kumanogoh, ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, Vol. 72, p. 820-820, 2013/06
  • トシリズマブ(抗IL-6受容体抗体)によりがん悪液質が改善し、化学療法を再開することができた進行非小細胞肺癌の2例, 合屋 将,木田 博,平田 陽彦,鉄本 訓史,木島 貴志,武田 吉人,吉崎 和幸,川瀬 一郎,立花 功,岸本 忠三,熊ノ郷 淳, 日本緩和医療学会学術大会プログラム・抄録集, (NPO)日本緩和医療学会, Vol. 18回, p. 335-335, 2013/06
  • Dynamic treatment regimen analysis to determine which treatment sequence can prolong survival of NSCLC patients., Taro Koba,Fumio Imamura,Satoshi Morita,Masahide Mori,Kiyoshi Komuta,Takashi Kijima,Yoshinobu Namba,Kazumi Nishino,Suguru Yamamoto,Ryo Takahashi,Yukie Nakazawa,Seigo Minami,Yoshitaka Ogata,Atsushi Kumanogoh, JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Vol. 31, No. 15, 2013/05
  • サルコイドーシス症例に対するEBUS-TBNAの有用性の検討, 高橋 良,平田 陽彦,東口 将佳,三宅 浩太郎,森村 治,南 俊行,河面 聡,井上 幸治,長友 泉,武田 吉人,木田 博,木島 貴志,立花 功,熊ノ郷 淳, 気管支学, (NPO)日本呼吸器内視鏡学会, Vol. 35, No. Suppl., p. S156-S156, 2013/05
  • レントゲン描出不能病変に対する経気管支生検を可能にする新しい読影法「スイッチオブリーク法」, 平田 陽彦,三宅 浩太郎,東口 将佳,森村 治,南 俊行,河面 聡,高橋 良,井上 幸治,長友 泉,武田 吉人,木田 博,木島 貴志,熊ノ郷 淳, 気管支学, (NPO)日本呼吸器内視鏡学会, Vol. 35, No. Suppl., p. S192-S192, 2013/05
  • 自己抗体 特発性非特異的間質性肺炎(Idiopathic NSIP)における疾患特異的自己抗体検索, 濱野 芳匡,木田 博,森島 淳仁,平野 亨,楢崎 雅司,嶋 良仁,緒方 篤,立花 功,田中 敏郎,熊ノ郷 淳, 日本リウマチ学会総会・学術集会・国際リウマチシンポジウムプログラム・抄録集, (一社)日本リウマチ学会, Vol. 57回・22回, p. 454-454, 2013/03
  • COPD 病因・病態 テトラスパニンCD9/CD81はSIRT1の制御によりアンチエイジング作用を示す, 武田 吉人,金 英姫,井上 幸治,木田 博,木島 貴志,伊藤 真里,立花 功,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 2, No. 増刊, p. 128-128, 2013/03
  • 超偏極129XeMRIによる新たなマウス肺気腫評価法確立, 鉄本 訓史,武田 吉人,金 英姫,中西 香織,前田 陽平,井上 幸治,長友 泉,木田 博,木島 貴志,立花 功,熊ノ郷 淳,今井 宏彦,木村 敦臣,近藤 康,伊藤 真里,重田 博, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 2, No. 増刊, p. 178-178, 2013/03
  • Double Deletion Of Tetraspanins Cd9 And Cd81 In Mice Spontaneously Develops Not Only COPD-Like Phenotype, But Also Multiple Aging Phenotypes, Y. Takeda,Y. Jin,S. Tetsumoto,Y. Kondo,M. Ito,I. Tachibana,A. Kumanogoh, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, Vol. 187, 2013
  • O7-5 サルコイドーシス症例に対するEBUS-TBNAの有用性の検討(EBUS-3,一般演題口演,第36回日本呼吸器内視鏡学会学術集会), 高橋 良,武田 吉人,木田 博,木島 貴志,立花 功,熊ノ郷 淳,平田 陽彦,東口 将佳,三宅 浩太郎,森村 治,南 俊行,河面 聡,井上 幸治,長友 泉, 気管支学, 特定非営利活動法人 日本呼吸器内視鏡学会, Vol. 35, No. 0, 2013
  • CTを気管支鏡に活かす古くて新しい手法と、LungPointとの比較, 三宅 浩太郎,東口 将佳,森村 治,南 俊行,河面 聡,平田 陽彦,高橋 良,長友 泉,井上 幸治,武田 吉人,木田 博,木島 貴志,立花 功,熊ノ郷 淳, 気管支学, (NPO)日本呼吸器内視鏡学会, Vol. 35, No. 1, p. 106-107, 2013/01
  • 難治性稀少肺疾患(肺胞蛋白症,先天性間質性肺疾患,オスラー病)に関する調査研究 蛋白アレイ法を用いた自己免疫性肺胞蛋白症の自己抗体解析に関する研究, 木田博,井上義一,濱野芳国,水口賢司,TRIPATHI Lokesh P,広瀬雅樹,多田康子,西川博嘉,熊ノ郷淳, 難治性稀少肺疾患(肺胞蛋白症、先天性間質性肺疾患、オスラー病)に関する調査研究 平成24年度 総括・分担研究報告書, p. 144-148, 2013
  • 当院における胸部悪性腫瘍に対するWT1ペプチド免疫療法, 武田 吉人,岡 芳弘,高橋 良,保仙 直毅,平田 陽彦,河面 聡,井上 幸治,長友 泉,木田 博,木島 貴志,大崎 匡,立花 功,熊ノ郷 淳,川瀬 一郎,尾路 祐介,杉山 治夫, 肺癌, (NPO)日本肺癌学会, Vol. 52, No. 7, p. 1076-1076, 2012/12
  • Comparison of Tolerability Between Tumor Necrosis Factor-Inhibitors and Tocilizumab for the Treatment of Rheumatoid Arthritis, Yoshihiro Hishitani,Yoshihito Shima,Toru Hirano,Keisuke Hagihara,Kosuke Ebina,Yasuo Kunugiza,Kenrin Shi,Masashi Narazaki,Atsushi Ogata,Tetsuya Tomita,Toshio Tanaka,Atsushi Kumanogoh, ARTHRITIS AND RHEUMATISM, WILEY-BLACKWELL, Vol. 64, No. 10, p. S219-S220, 2012/10
  • 再発ハイリスク同種造血幹細胞移植後患者に対するWT1ペプチドワクチン第1相臨床試験, 保仙 直毅,前田 哲生,福島 健太郎,森本 創世子,中田 潤,中江 吉希,西田 純幸,坪井 昭博,近藤 忠一,門脇 則光,日野 雅之,尾路 祐介,岡 芳弘,熊ノ郷 淳,金倉 譲,杉山 治夫, 臨床血液, (一社)日本血液学会-東京事務局, Vol. 53, No. 9, p. 1051-1051, 2012/09
  • 分子標的治療による小細胞肺癌の抗癌剤耐性の克服(Molecular targeting therapy to overcome chemoresistance in small cell lung cancer), 南 俊行,木島 貴志,河面 聡,大谷 安司,高橋 良,長友 泉,武田 吉人,立花 功,熊ノ郷 淳, 日本癌学会総会記事, 日本癌学会, Vol. 71回, p. 120-120, 2012/08
  • 肺扁平上皮癌悪液質に対して抗IL-6R抗体Tocilizumab投与で症状改善の得られた1症例, 片岡 祐,平田 陽彦,木田 博,井上 幸治,大谷 安司,高橋 良,長友 泉,武田 吉人,木島 貴志,立花 功,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 52, No. 3, p. 349-349, 2012/06
  • Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer, Takayuki Shiroyama,Takashi Kijima,Kiyoshi Komuta,Suguru Yamamoto,Seigo Minami,Yoshitaka Ogata,Kouhei Okafuji,Fumio Imamura,Tomonori Hirashima,Isao Tachibana,Ichiro Kawase,Atsushi Kumanogoh, JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Vol. 30, No. 15, 2012/05
  • What factors affect long-term survival after responding to gefitinib in advanced non-small cell lung cancer? Real-world evidence, Yoshiko Takeuchi,Fumio Imamura,Satoshi Morita,Masahide Mori,Kiyoshi Komuta,Takashi Kijima,Yoshinobu Namba,Kazumi Nishino,Suguru Yamamoto,Ryo Takahashi,Yukie Nakazawa,Seigo Minami,Yoshitaka Ogata,Atsushi Kumanogoh, JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Vol. 30, No. 15, 2012/05
  • HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer, Toshiyuki Minami,Takashi Kijima,Yasushi Otani,Satoshi Kohmo,Ryo Takahashi,Izumi Nagatomo,Haruhiko Hirata,Mayumi Suzuki,Koji Inoue,Yoshito Takeda,Hiroshi Kida,Isao Tachibana,Atsushi Kumanogoh, CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72, 2012/04
  • 大阪大学における生物学的製剤の使用経験, 菱谷好洋,平野亨,嶋良仁,萩原圭祐,楢崎雅司,緒方篤,蛯名耕介,史賢林,椚座康夫,冨田哲也,田中敏郎,熊ノ郷淳, 日本リウマチ学会総会・学術集会・国際リウマチシンポジウムプログラム・抄録集, Vol. 56th-21st, 2012/03/19
  • Treatment failure of tocilizumab in two patients with psoriatic arthritis, Atsushi Ogata,Noriko Umegaki,Ichiro Katayama,Atsushi Kumanogoh,Toshio Tanaka, Revue du Rhumatisme (Edition Francaise), Vol. 79, No. 2, p. 168-170, 2012/03
  • COPD 基礎 テトラスパニンCD9/CD81二重欠損マウスはCOPDモデル?それとも老化モデル?, 武田 吉人,金 英姫,辻野 和之,鈴木 真優美,井上 幸治,木田 博,木島 貴志,立花 功,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 1, No. 増刊, p. 115-115, 2012/03
  • マクロファージCD9/CD81を増強させるCOPD治療薬の探索, 金 英姫,立花 功,武田 吉人,鈴木 真優美,辻野 和之,久原 華子,鉄本 訓史,木田 博,木島 貴志,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 1, No. 増刊, p. 137-137, 2012/03
  • CD151は肺胞上皮の安定化を介して肺の線維化を制御する, 辻野 和之,武田 吉人,金 英姫,鉄本 訓史,岩崎 剛雄,井上 幸治,木田 博,木島 貴志,立花 功,熊ノ郷 淳,新井 徹,北市 正則,井上 義一, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 1, No. 増刊, p. 243-243, 2012/03
  • CXCR 4阻害剤TF 14016の小細胞肺癌転移抑制効果の検討, 大谷 安司,木島 貴志,河面 聡,南 俊行,長友 泉,高橋 良,平田 陽彦,井上 幸治,鈴木 真優美,武田 吉人,木田 博,立花 功,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 1, No. 増刊, p. 244-244, 2012/03
  • 肺化学発癌モデルにおけるStat 3の抗腫瘍免疫抑制効果, 井原 祥一,木田 博,吉田 光宏,平田 陽彦,井上 幸治,長友 泉,武田 吉人,木島 貴志,立花 功,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 1, No. 増刊, p. 245-245, 2012/03
  • 呼気揮発性有機成分による肺癌検診システムの開発, 木田 博,東口 将佳,松岡 洋人,山本 傑,長友 泉,平田 陽彦,平島 智徳,宍戸 克子,石原 英樹,立花 功,小牟田 清,川瀬 一郎,熊ノ郷 淳, 日本呼吸器学会誌, (一社)日本呼吸器学会, Vol. 1, No. 増刊, p. 246-246, 2012/03
  • Regulation of immune cell responses by semaphorins and their receptors, Atsushi Kumanogoh,Hyota Takamatsu, ARTHRITIS RESEARCH & THERAPY, BIOMED CENTRAL LTD, Vol. 14, 2012
  • Sema3E promotes migration of Th17 cells during the course of experimental autoimmune encephalomyelitis, T. Okuno,Y. Nakatsuji,S. Sakoda,A. Kumanogoh, MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Vol. 17, p. S328-S328, 2011/10
  • Elevation of Sema4A implicates Th17 skewing and the efficacy of interferon-beta therapy in multiple sclerosis, Y. Nakatsuji,T. Okuno,M. Moriya,T. Sugimoto,M. Kinoshita,K. Takata,M. Nakano,S. Sakoda,A. Kumanogoh, MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Vol. 17, p. S502-S502, 2011/10
  • HER2陽性抗癌剤耐性小細胞肺癌におけるLapatinibのABCトランスポーター阻害効果(Lapatinib reverses ABC transporter-mediated multi-drug resistance especially in HER2-positive Small Cell Lung Cancer), 南 俊行,木島 貴志,大谷 安司,河面 聡,高橋 良,長友 泉,武田 吉人,立花 功,熊ノ郷 淳, 日本癌学会総会記事, 日本癌学会, Vol. 70回, p. 405-405, 2011/09
  • Crizotinib治療を受けたEML4-ALK陽性肺腺癌患者3例の報告, 野里 聡子,木島 貴志,鉄本 訓史,島田 和貴,高橋 良,大谷 安司,平田 陽彦,井上 幸治,長友 泉,武田 吉人,木田 博,立花 功,熊ノ郷 淳,合屋 将,川瀬 一郎, 肺癌, (NPO)日本肺癌学会, Vol. 51, No. 4, p. 294-294, 2011/08
  • EGFR-TKI治療経過中の腫瘍マーカーの推移をどう読むか?, 井藤 英之,木島 貴志,大谷 安司,高橋 良,平田 陽彦,井上 幸治,長友 泉,武田 吉人,木田 博,立花 功,熊ノ郷 淳, 肺癌, (NPO)日本肺癌学会, Vol. 51, No. 4, p. 295-295, 2011/08
  • 悪性腫瘍に対するWT1ペプチドワクチン治療-特に,造血器腫瘍に焦点をあてて-, 岡 芳弘,坪井 昭博,西田 純幸,保仙 直毅,中田 潤,橋井 佳子,前田 哲生,尾路 祐介,熊ノ郷 淳,杉山 治夫, 臨床血液, Vol. 52, p. 235-242, 2011
  • Sema3E is involved in the migration of CD4+T cell during the course of experimental autoimmune encephalomyelitis (EAE), Takamatsu Hyota,Nakatsuji Yuji,Nojima Satoshi,Kumanogoh Atsushi,Okuno Tatsusada, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 228, No. 1-2, p. 140-140, 2010/11
  • Sema4A is a serum diagnostic marker of Multiple Sclerosis, which reflects the TH17 shift of PBMC, Nakatsuji Yuji,Okuno Tatsusada,Moriya Masayuki,Sugimoto Tomoyuki,Kinoshita Makoto,Nakano Misa,Kikutani Hitoshi,Sakoda Saburo,Kumanogoh Atsushi, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 228, No. 1-2, p. 187-188, 2010/11
  • Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells, Kinoshita Makoto,Nakatsuji Yuji,Kimura Takashi,Moriya Masayuki,Takata Kazushiro,Okuno Tatsusada,Kumanogoh Atsushi,Kajiyama Koji,Yoshikawa Hiroo,Sakoda Saburo, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 228, No. 1-2, p. 18-18, 2010/11
  • Involvement of semaphorins and their receptors in neurological diseases, Noriko Takegahara,Atsushi Kumanogoh, Clinical and Experimental Neuroimmunology, Vol. 1, No. 1, p. 33-45, 2010/01
  • Sema4D/CD100 deficiency leads to superior performance in mouse motor behavior, Takuji Ito,Tetsuji Tanaka,Kenji Yoshida,Noriko Takeuchi,Hitoshi Kikutani,Atsushi Kumanogoh,Kazunori Yukawa, NEUROSCIENCE RESEARCH, ELSEVIER IRELAND LTD, Vol. 68, p. E182-E182, 2010
  • Mechanism of postnatal vaginal tissue remodeling induced by Sema4D/CD100 in mice, Takuji Ito,Bai Tao,Tetsuji Tanaka,Takashi Ueyama,Kenji Yoshida,Noriko Takeuchi,Hyota Takamatsu,Hitoshi Kikutani,Atsushi Kumanogoh,Kazunori Yukawa, JOURNAL OF PHYSIOLOGICAL SCIENCES, SPRINGER TOKYO, Vol. 60, p. S186-S186, 2010
  • Semaphorin 7A promotes thalamocortical axon branching and presynaptic differentiation, Akiko Fukunishi,Takuro Maruyama,Hong Zhao,Manisha Tiwari,Kang Sujin,Atsushi Kumanogoh,Nobuhiko Yamamoto, NEUROSCIENCE RESEARCH, ELSEVIER IRELAND LTD, Vol. 68, p. E62-E62, 2010
  • Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum, M. Kinoshita,Y. Nakatsuji,M. Moriya,T. Okuno,A. Kumanogoh,M. Nakano,T. Takahashi,K. Fujihara,K. Tanaka,S. Sakoda, MULTIPLE SCLEROSIS, SAGE PUBLICATIONS LTD, Vol. 15, No. 9, p. S192-S193, 2009/09
  • Sema4A as a diagnostic marker and its pathogenic roles in multiple sclerosis, Y. Nakatsuji,M. Moriya,T. Okuno,M. Kinoshita,T. Sugimoto,M. Nakano,H. Kikutani,S. Sakoda,A. Kumanogoh, MULTIPLE SCLEROSIS, SAGE PUBLICATIONS LTD, Vol. 15, No. 9, p. S79-S79, 2009/09
  • 破骨細胞分化における免疫受容体会合性シグナルアダプター分子DAP10の重要性, 藤村 紫音,乾 匡範,菊地 佑樹,青木 直子,遠藤 章太,前田 努,飛内 章子,原,中村 晃,熊ノ郷 淳,Colonna Marco,高井 俊行, Clinical Calcium, (株)医薬ジャーナル社, Vol. 19, No. 6, p. 860-860, 2009/05
  • アレルギー 気道炎症などを中心にして 抗原特異的アレルギー性喘息及び鼻炎に対するSema4Aの抑制的役割(An inhibitory role of Sema4A in antigen specific allergic asthma and rhinitis), 森鼻 哲生,Durubaka Prasad,安居 輝人,熊ノ郷 淳,菊谷 仁, 日本免疫学会総会・学術集会記録, (NPO)日本免疫学会, Vol. 38, p. 41-41, 2008/11
  • The expression of the semaphorin in the spinal cord of EAE and its relevance to immune cell trafficking, Masayuki Moriya,Yuji Nakatsuji,Atsushi Kumanogoh,Tatsusada Okuno,Makoto Kinoshita,Ayako Konomi,Saburo Sakoda, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 203, No. 2, p. 146-146, 2008/10
  • Elevated serum Sema4A level in patients with multiple sclerosis, Yuji Nakatsuji,Masayuki Moriya,Tatsusada Okuno,Makoto Kinoshita,Tomoyuki Sugimoto,Ayako Konomi,Misa Nakano,Hitoshi Kikutani,Atsushi Kumanogoh,Saburo Sakoda, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 203, No. 2, p. 129-129, 2008/10
  • Role of Sema4D in the neuroinflammation of experimental autoimmune encephalomyelitis, Tatsusada Okuno,Yuji Nakatsuji,Saburo Sakoda,Atsushi Kumanogoh, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 203, No. 2, p. 230-230, 2008/10
  • Defective activation of phospholipase C gamma 2 by collagen in platelets lacking the semaphorin family member, sema4D, Li Zhu,Hong Jiang,Atsushi Kumanogoh,Hitoshi Kikutani,Lawrence F. Brass, BLOOD, AMER SOC HEMATOLOGY, Vol. 110, No. 11, p. 129A-130A, 2007/11
  • ENDOGENOUS SEMA 4D (CD100) PROMOTES GLOMERULAR INJURY IN EXPERIMENTAL ANTI-GBM GLOMERULONEPHRITIS, A. R. Kitching,M. Li,K. M. O'Sullivan,L. K. Jones,C. Lo,T. Semple,A. Kumanogoh,H. Kikutani,S. R. Holdsworth, NEPHROLOGY, WILEY-BLACKWELL, Vol. 12, p. A36-A36, 2007/09
  • A novel role of class IV sernaphorin Sema4D CD100 in the neuroinflammation, Tatsusada Okuno,Yuji Nakatsuji,Atsushi Kumanogoh,Masayuki Moriya,Hitoshi Kikutani,Saburo Sakoda, JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE BV, Vol. 178, p. 145-145, 2006/09
  • A critical role of SEMA4D (CD 100) in reducing graft-versus-host disease in a murine major mismatch transplant, R Duran-Struuck,C Rogers,S Clouthier,E Gatza,C Liu,A Kumanogoh,P Reddy,JLM Ferrara, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, CARDEN JENNINGS PUBL CO LTD, Vol. 12, No. 2, p. 59-60, 2006/02
  • Molecular mechanisms for signaling through plexin-A1, Hitoshi Kikutani,Atsushi Kumanogoh,Toshihiko Toyofuku, NEUROSCIENCE RESEARCH, ELSEVIER IRELAND LTD, Vol. 55, p. S30-S30, 2006
  • Semaphorins in the immune system, A. Kumanogoh,T. Shikina,K. Suzuki,M. Yamamoto,H. Takamatsu,N. Takegahara,S. Marukawa,I. Ishida,D. V.R. Prasad,T. Toyofuku,H. Kikutani, International Congress Series, Vol. 1285, p. 202-206, 2005/11
  • A Pathogenetic Role for Sernaphorins in Renal Injury: CD100 enhances pathogenetic humoral immune responses by promoting T cell-APC interaction, Ming Li,Kim O'Sullivan,Lynelle K. Jones,Atsushi Kumanogoh,Hitoshi Kikutani,Stephen R. Holdsworth,Richard A. Kitching, INFLAMMATION RESEARCH, BIRKHAUSER VERLAG AG, Vol. 54, p. S209-S209, 2005/08
  • 免疫セマフォリン分子Sema4AのTh1/Th2制御における役割, 識名 崇,熊ノ郷 淳,鈴木 一博,植松 智,筒井 ひろ子,審良 静男,竹田 潔,菊谷 仁, 日本免疫学会総会・学術集会記録, (NPO)日本免疫学会, Vol. 34, p. 232-232, 2004/11
  • Semaphorin4A suppresses angiogenesis via binding to plexinD1, M Yabuki,T Toyofuku,J Kamei,K Harada,M Hori,A Kumanogoh,H Kikutani, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 110, No. 17, p. 305-306, 2004/10
  • Biological functions and signaling of a transmembrane semaphorin, CD100/Sema4D, A Kumanogoh,H Kikutani, CELLULAR AND MOLECULAR LIFE SCIENCES, BIRKHAUSER VERLAG AG, Vol. 61, No. 3, p. 292-300, 2004/02
  • Semaphorin 4D (CD100) is expressed on the surface of human platelets and proteolytically shed during platelet activation., L Zhu,N Prevost,Lee, V,D Woulfe,J Scheidel,HH Yang,J Wu,H Jiang,A Kumanogoh,H Kikutani,L Boumsell,L Tamagnone,L Brass, BLOOD, AMER SOC HEMATOLOGY, Vol. 102, No. 11, p. 292A-292A, 2003/11
  • Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2., Atsushi Kumanogoh,Satoko Marukawa,Kazuhiro Suzuki,Noriko Takegahara,Chie Watanabe,EweSeng Ch'ng,Isao Ishida,Harutoshi Fujimura,Saburo Sakoda,Kanji Yoshida,Hitoshi Kikutani, Nature, Vol. 419, No. 6907, p. 629-33, 2002/10/10
  • アレルギー性気道炎におけるリンパ球セマフォリン分子CD100の意義, 合屋 将,森下 裕,木田 博,森 雅秀,松岡 洋人,吉田 光宏,林 清二,川瀬 一郎,熊ノ郷 淳,菊谷 仁, 日本呼吸器学会雑誌, (一社)日本呼吸器学会, Vol. 40, No. 増刊, p. 128-128, 2002/03
  • Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses, XS Wang,A Kumanogoh,C Watanabe,W Shi,K Yoshida,H Kikutani, BLOOD, AMER SOC HEMATOLOGY, Vol. 97, No. 11, p. 3498-3504, 2001/06
  • "Semaphorins" in the immune regulation, A Kumanogoh,K Suzuki,C Watanabe,S Marukawa,N Takegahara,ES Ch'ng,H Kikutani, JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, p. 20-20, 2001
  • The CD100-CD72 interactions : a novel mechanism of immune regulation, Treds in Immunology, Vol. 22 : 670-676, 2001
  • Enhanced immune responres in transgenic mice expressing a turncated form of the lymphocyte semaplorin CD100/Sema4D, The Journal of Immunology, Vol. 167, 4321-4328, 2001
  • Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development, A Kumanogoh,XS Wang,Lee, I,C Watanabe,M Kamanaka,W Shi,K Yoshida,T Sato,S Habu,M Itoh,N Sakaguchi,S Sakaguchi,H Kikutani, JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 166, No. 1, p. 353-360, 2001/01
  • TRAF3欠損マウスにおけるT細胞ネガティブセレクション障害の解析, 内田 純二,安居 輝人,石田 勲,吉田 謙二,熊ノ郷 淳,菊谷 仁, 日本免疫学会総会・学術集会記録, (NPO)日本免疫学会, Vol. 30, p. 91-91, 2000/11
  • gp130-dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation, E Tone,K Kunisada,A Kumanogoh,S Negoro,M Funamoto,T Osugi,T Kishimoto,K Yamauchi-Takihara, CYTOKINE, W B SAUNDERS CO, Vol. 12, No. 10, p. 1512-1518, 2000/10
  • The class (]G0004[) semaphorin CD100 plays nonredundant roles in the immune system : Defective B and T cell activation in CD100-deficient mice, Immunity(Cell press), No. 13, p. 633-642, 2000
  • Identification of CD72 as a lymphocyte receptor for the class (]G0004[) semaphorin CD100 : A novel mechanism for regulating B cell signaling, Immunity(Cell press), No. 13, p. 621-631, 2000
  • B細胞特異的にCD100/Sema4Dを過剰発現するtransgenic mouseの作成と機能解析, 渡辺 知恵,熊ノ郷 淳,施 維,王 暁松,安居 輝人,菊谷 仁, 日本免疫学会総会・学術集会記録, (NPO)日本免疫学会, Vol. 29, p. 75-75, 1999/10
  • CD40シグナル改変マウスにおけるB細胞分化機構の解析, 安居 輝人,村岡 正章,七條 優子,内田 純二,熊ノ郷 淳,菊谷 仁, 日本臨床免疫学会会誌, 日本臨床免疫学会, No. 26回抄録集, p. 98-98, 1998/10
  • Subtracted-PCR法を用いたCD40-target geneの同定, 施 維,熊ノ郷 淳,李 仁淑,内田 純二,安居 輝人,吉田 寛二,菊谷 仁, 日本臨床免疫学会会誌, 日本臨床免疫学会, No. 26回抄録集, p. 375-375, 1998/10
  • Impairment of antigen specific antibody production and acute-phase protein induction in transgenic mice expressing a dominant-negative form of gp130. (共著), Lenkocyte Typing VI, 1997
  • Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130. (共著), Proceedings of National Academic Science in USA., Vol. 94, 1997
  • Dominant-negative gp130 transgenic mice作成によるgp130の免疫系における機能解析, 日本免疫学会, 1996
  • The immunological functions of gp130 in transgenic mice expressing a dominant-negative form of gp130., 1996
  • Impairment of antibody production in transgenic mice overexpressing a dominant-negative form of gp130, The 6th international work shop and conference on human lenkocyte differentiation antigens, 1996
  • Impairment of antibody production in transgenic mice overexpressing a dominant-negative form of gp130. (共著), Tissue Antigens, Vol. 48, 1996
  • Targeted disruption of gp130, a common signal transducer for the IL-6 family of cytokines leads to myocardial and hemato logical disorders. (共著), Proceedings of National Academic Science in USA, Vol. 93, No. 1, p. 407-411, 1996
  • IL-6 induced growth and differentiation signals are mediated by distinct regions of the cytoplasmic domain of the signal transducer, gp130, The 9th international congress of immunology, 1995
  • Disruption of the gene for the shared cytokine signal transducer, gp130. (共著), Lenkocyte Typing V, 1994
  • Effects of therapy on anterior pituitary functions in patients with primary intracranial germ cell tumor. (共著), ATSUSHI KUMANOGOH,SOJI KASAYAMA,HARUHIKO KOUHARA,MASAFUMI KOGA,NORIO ARITA,TORU HAYAKAWA,TADAMITSU KISHIMOTO,BUNZO SATO, Endocrine Journal, Vol. 41, No. 3, p. 287-292, 1994
  • Differentiation of thymocytes from CD3<sup>-</sup>CD4<sup>-</sup>CD8<sup>-</sup> through CD3<sup>-</sup>CD4<sup>-</sup>CD8<sup>+</sup> into move mature stages induced by a thymic stromal cell clone. (共著), Proceedings of National Academic Sciences in USA, Vol. 87, 1990